WO2016030060A1 - Anti body odor preparations which are low in electrolytes - Google Patents
Anti body odor preparations which are low in electrolytes Download PDFInfo
- Publication number
- WO2016030060A1 WO2016030060A1 PCT/EP2015/065181 EP2015065181W WO2016030060A1 WO 2016030060 A1 WO2016030060 A1 WO 2016030060A1 EP 2015065181 W EP2015065181 W EP 2015065181W WO 2016030060 A1 WO2016030060 A1 WO 2016030060A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cosmetic
- composition according
- weight
- cosmetic composition
- carbon atoms
- Prior art date
Links
- 208000035985 Body Odor Diseases 0.000 title description 11
- 206010040904 Skin odour abnormal Diseases 0.000 title description 11
- 239000003792 electrolyte Substances 0.000 title description 5
- 238000002360 preparation method Methods 0.000 title description 5
- 239000002537 cosmetic Substances 0.000 claims abstract description 65
- 239000002781 deodorant agent Substances 0.000 claims abstract description 55
- 229910052751 metal Inorganic materials 0.000 claims abstract description 9
- 239000002184 metal Substances 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 70
- 125000004432 carbon atom Chemical group C* 0.000 claims description 38
- 239000003795 chemical substances by application Substances 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 26
- 239000004480 active ingredient Substances 0.000 claims description 22
- 239000003380 propellant Substances 0.000 claims description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- 150000002148 esters Chemical class 0.000 claims description 13
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 12
- 239000001069 triethyl citrate Substances 0.000 claims description 12
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 12
- 235000013769 triethyl citrate Nutrition 0.000 claims description 12
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical class C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 11
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000443 aerosol Substances 0.000 claims description 10
- 229960005323 phenoxyethanol Drugs 0.000 claims description 10
- 239000007921 spray Substances 0.000 claims description 9
- 229940031723 1,2-octanediol Drugs 0.000 claims description 8
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 claims description 4
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical class CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 4
- 150000004788 tropolones Chemical class 0.000 claims description 4
- IDGMBCFBOMJIMX-UHFFFAOYSA-N 5-cyclohexyl-2-methylpentan-1-ol Chemical compound OCC(C)CCCC1CCCCC1 IDGMBCFBOMJIMX-UHFFFAOYSA-N 0.000 claims description 3
- 125000002723 alicyclic group Chemical group 0.000 claims description 3
- 150000007824 aliphatic compounds Chemical class 0.000 claims description 3
- 150000001733 carboxylic acid esters Chemical group 0.000 claims description 3
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 claims description 3
- ZQBULZYTDGUSSK-UHFFFAOYSA-N (3-hydroxy-2-octanoyloxypropyl) octanoate Chemical class CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC ZQBULZYTDGUSSK-UHFFFAOYSA-N 0.000 claims description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical class CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 claims description 2
- 150000002009 diols Chemical class 0.000 claims 1
- 238000005260 corrosion Methods 0.000 abstract description 11
- 230000007797 corrosion Effects 0.000 abstract description 11
- 239000007788 liquid Substances 0.000 description 15
- 239000003205 fragrance Substances 0.000 description 14
- 239000003112 inhibitor Substances 0.000 description 12
- -1 alkyl radical Chemical class 0.000 description 10
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000002304 perfume Substances 0.000 description 8
- 239000000470 constituent Substances 0.000 description 7
- 229940060184 oil ingredients Drugs 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 6
- MDYOLVRUBBJPFM-UHFFFAOYSA-N Tropolone Natural products OC1=CC=CC=CC1=O MDYOLVRUBBJPFM-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 102000009133 Arylsulfatases Human genes 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 108010076010 Cystathionine beta-lyase Proteins 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 108060007951 sulfatase Proteins 0.000 description 5
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 4
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 4
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 4
- 102000053187 Glucuronidase Human genes 0.000 description 4
- 108010060309 Glucuronidase Proteins 0.000 description 4
- 230000001166 anti-perspirative effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000003213 antiperspirant Substances 0.000 description 4
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000005028 tinplate Substances 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 229940015975 1,2-hexanediol Drugs 0.000 description 3
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 3
- CGMOOAUESLSUKM-UHFFFAOYSA-N 2-benzylheptan-1-ol Chemical compound CCCCCC(CO)CC1=CC=CC=C1 CGMOOAUESLSUKM-UHFFFAOYSA-N 0.000 description 3
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000186216 Corynebacterium Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- FLUWAIIVLCVEKF-UHFFFAOYSA-N 2-Methyl-1-phenyl-2-propanyl acetate Chemical compound CC(=O)OC(C)(C)CC1=CC=CC=C1 FLUWAIIVLCVEKF-UHFFFAOYSA-N 0.000 description 2
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 239000004604 Blowing Agent Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229940007550 benzyl acetate Drugs 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N beta-Carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 229940095104 dimethyl benzyl carbinyl acetate Drugs 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 210000002768 hair cell Anatomy 0.000 description 2
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- BSAIUMLZVGUGKX-UHFFFAOYSA-N non-2-enal Chemical compound CCCCCCC=CC=O BSAIUMLZVGUGKX-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N phenethyl acetate Chemical compound CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 244000005714 skin microbiome Species 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 150000003464 sulfur compounds Chemical class 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- DYIOSHGVFJTOAR-JGWLITMVSA-N (2r,3r,4s,5r)-6-sulfanylhexane-1,2,3,4,5-pentol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CS DYIOSHGVFJTOAR-JGWLITMVSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- YPZUZOLGGMJZJO-XRGAULLZSA-N (3as,5as,9as,9br)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1h-benzo[e][1]benzofuran Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)[C@@H]1[C@@]2(C)OCC1 YPZUZOLGGMJZJO-XRGAULLZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- YYMCVDNIIFNDJK-XFQWXJFMSA-N (z)-1-(3-fluorophenyl)-n-[(z)-(3-fluorophenyl)methylideneamino]methanimine Chemical compound FC1=CC=CC(\C=N/N=C\C=2C=C(F)C=CC=2)=C1 YYMCVDNIIFNDJK-XFQWXJFMSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WCIQNYOXLZQQMU-UHFFFAOYSA-N 1-Phenylethyl propanoate Chemical compound CCC(=O)OC(C)C1=CC=CC=C1 WCIQNYOXLZQQMU-UHFFFAOYSA-N 0.000 description 1
- PKXSPCMDZCKLCI-UHFFFAOYSA-N 1-cyclohexylpentan-1-ol Chemical compound CCCCC(O)C1CCCCC1 PKXSPCMDZCKLCI-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FYMOBFDUZIDKMI-UHFFFAOYSA-N 2,2-dimethyl-3-(3-methylphenyl)propan-1-ol Chemical compound CC1=CC=CC(CC(C)(C)CO)=C1 FYMOBFDUZIDKMI-UHFFFAOYSA-N 0.000 description 1
- VNGAHMPMLRTSLF-UHFFFAOYSA-N 2,2-dimethyl-3-phenylpropan-1-ol Chemical compound OCC(C)(C)CC1=CC=CC=C1 VNGAHMPMLRTSLF-UHFFFAOYSA-N 0.000 description 1
- IYOLBFFHPZOQGW-UHFFFAOYSA-N 2,4-dichloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=C(Cl)C(C)=C1Cl IYOLBFFHPZOQGW-UHFFFAOYSA-N 0.000 description 1
- DTFBBVDDPVULMK-UHFFFAOYSA-N 2-(aminomethylidene)propanedioic acid Chemical class NC=C(C(O)=O)C(O)=O DTFBBVDDPVULMK-UHFFFAOYSA-N 0.000 description 1
- MJTPMXWJHPOWGH-UHFFFAOYSA-N 2-Phenoxyethyl isobutyrate Chemical compound CC(C)C(=O)OCCOC1=CC=CC=C1 MJTPMXWJHPOWGH-UHFFFAOYSA-N 0.000 description 1
- SRGFNTJXOXXONL-UHFFFAOYSA-N 2-[(2-chlorophenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=CC=C1Cl SRGFNTJXOXXONL-UHFFFAOYSA-N 0.000 description 1
- FJSUGPQOEGHQKE-UHFFFAOYSA-N 2-[(2-methylphenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=CC=C1C FJSUGPQOEGHQKE-UHFFFAOYSA-N 0.000 description 1
- JCKHRARZZAGBIS-UHFFFAOYSA-N 2-[(3,4-dichlorophenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=C(Cl)C(Cl)=C1 JCKHRARZZAGBIS-UHFFFAOYSA-N 0.000 description 1
- WGASUOJCGSAPKF-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=C(OC)C(OC)=C1 WGASUOJCGSAPKF-UHFFFAOYSA-N 0.000 description 1
- IPKDTCSGMIQVRX-UHFFFAOYSA-N 2-[(3,4-dimethylphenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=C(C)C(C)=C1 IPKDTCSGMIQVRX-UHFFFAOYSA-N 0.000 description 1
- UUMMYPQHKYZKCK-UHFFFAOYSA-N 2-[(3-chlorophenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=CC(Cl)=C1 UUMMYPQHKYZKCK-UHFFFAOYSA-N 0.000 description 1
- GAQMPRCAMOFUFL-UHFFFAOYSA-N 2-[(3-methylphenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=CC(C)=C1 GAQMPRCAMOFUFL-UHFFFAOYSA-N 0.000 description 1
- GXLNZLYPKFGOPX-UHFFFAOYSA-N 2-[(4-chlorophenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=C(Cl)C=C1 GXLNZLYPKFGOPX-UHFFFAOYSA-N 0.000 description 1
- MFIZLDGBJIGZNK-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=C(OC)C=C1 MFIZLDGBJIGZNK-UHFFFAOYSA-N 0.000 description 1
- GCJCKBVFEMPAEF-UHFFFAOYSA-N 2-[(4-methylphenyl)methyl]butan-1-ol Chemical compound CCC(CO)CC1=CC=C(C)C=C1 GCJCKBVFEMPAEF-UHFFFAOYSA-N 0.000 description 1
- ZJVJPPNOQCMEPI-UHFFFAOYSA-N 2-[ethyl(methyl)amino]-2-phenylacetic acid Chemical compound CCN(C)C(C(O)=O)C1=CC=CC=C1 ZJVJPPNOQCMEPI-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- HDWHPQGCZQJPCG-UHFFFAOYSA-N 2-benzylbutan-1-ol Chemical compound CCC(CO)CC1=CC=CC=C1 HDWHPQGCZQJPCG-UHFFFAOYSA-N 0.000 description 1
- TYBHZVUFOINFDV-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol Chemical compound OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O TYBHZVUFOINFDV-UHFFFAOYSA-N 0.000 description 1
- DRTBYQJIHFSKDT-UHFFFAOYSA-N 2-methyl-5-phenylpentan-1-ol Chemical compound OCC(C)CCCC1=CC=CC=C1 DRTBYQJIHFSKDT-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- UNDXPKDBFOOQFC-UHFFFAOYSA-N 4-[2-nitro-4-(trifluoromethyl)phenyl]morpholine Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1N1CCOCC1 UNDXPKDBFOOQFC-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- KFZXVMNBUMVKLN-UHFFFAOYSA-N 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC(Cl)=C(C)C=C1O KFZXVMNBUMVKLN-UHFFFAOYSA-N 0.000 description 1
- YXVSKJDFNJFXAJ-UHFFFAOYSA-N 4-cyclohexyl-2-methylbutan-2-ol Chemical compound CC(C)(O)CCC1=CC=CC=C1 YXVSKJDFNJFXAJ-UHFFFAOYSA-N 0.000 description 1
- LDZLXQFDGRCELX-UHFFFAOYSA-N 4-phenylbutan-1-ol Chemical compound OCCCCC1=CC=CC=C1 LDZLXQFDGRCELX-UHFFFAOYSA-N 0.000 description 1
- MBZRJSQZCBXRGK-UHFFFAOYSA-N 4-tert-Butylcyclohexyl acetate Chemical compound CC(=O)OC1CCC(C(C)(C)C)CC1 MBZRJSQZCBXRGK-UHFFFAOYSA-N 0.000 description 1
- DPZMVZIQRMVBBW-UHFFFAOYSA-N 5-Phenyl-1-pentanol Chemical compound OCCCCCC1=CC=CC=C1 DPZMVZIQRMVBBW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 229940087064 Beta-glucuronidase inhibitor Drugs 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 101000583175 Homo sapiens Prolactin-inducible protein Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical class OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 241000234269 Liliales Species 0.000 description 1
- 229940086609 Lipase inhibitor Drugs 0.000 description 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 102100030350 Prolactin-inducible protein Human genes 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000584803 Xanthosia rotundifolia Species 0.000 description 1
- LMETVDMCIJNNKH-UHFFFAOYSA-N [(3,7-Dimethyl-6-octenyl)oxy]acetaldehyde Chemical compound CC(C)=CCCC(C)CCOCC=O LMETVDMCIJNNKH-UHFFFAOYSA-N 0.000 description 1
- ISRLGZXSKRDKID-JXBDSQKUSA-N [3-bis[3-[dimethyl-[3-[[(9z,12z)-octadeca-9,12-dienoyl]amino]propyl]azaniumyl]-2-hydroxypropoxy]phosphoryloxy-2-hydroxypropyl]-dimethyl-[3-[[(9z,12z)-octadeca-9,12-dienoyl]amino]propyl]azanium;trichloride Chemical compound [Cl-].[Cl-].[Cl-].CCCCC\C=C/C\C=C/CCCCCCCC(=O)NCCC[N+](C)(C)CC(O)COP(=O)(OCC(O)C[N+](C)(C)CCCNC(=O)CCCCCCC\C=C/C\C=C/CCCCC)OCC(O)C[N+](C)(C)CCCNC(=O)CCCCCCC\C=C/C\C=C/CCCCC ISRLGZXSKRDKID-JXBDSQKUSA-N 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- QUMXDOLUJCHOAY-UHFFFAOYSA-N alpha-methylbenzyl acetate Natural products CC(=O)OC(C)C1=CC=CC=C1 QUMXDOLUJCHOAY-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 108010033961 beta-glucuronidase inhibitor Proteins 0.000 description 1
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-isopropyltropolone Natural products CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 1
- 229940090972 beta-thujaplicin Drugs 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- FZJUFJKVIYFBSY-UHFFFAOYSA-N bourgeonal Chemical compound CC(C)(C)C1=CC=C(CCC=O)C=C1 FZJUFJKVIYFBSY-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940031956 chlorothymol Drugs 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- ZDOYGJNADZJRFB-PVMVIUQGSA-L copper (17S,18S)-18-(2-carboxyethyl)-20-(carboxymethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylic acid Chemical class [Cu++].CCc1c(C)c2cc3[n-]c(cc4nc([C@@H](CCC(O)=O)[C@@H]4C)c(CC(O)=O)c4[n-]c(cc1n2)c(C)c4C(O)=O)c(C)c3C=C ZDOYGJNADZJRFB-PVMVIUQGSA-L 0.000 description 1
- 239000003581 cosmetic carrier Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940019836 cyclamen aldehyde Drugs 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- NUQDJSMHGCTKNL-UHFFFAOYSA-N cyclohexyl 2-hydroxybenzoate Chemical compound OC1=CC=CC=C1C(=O)OC1CCCCC1 NUQDJSMHGCTKNL-UHFFFAOYSA-N 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- SDNPOUURRJTUJP-UHFFFAOYSA-N ethenylazanium;acetate Chemical compound NC=C.CC(O)=O SDNPOUURRJTUJP-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003897 fog Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WKEWHSLZDDZONF-UHFFFAOYSA-N gammar-Thujaplicin Natural products CC(C)C1=CC=C(O)C(=O)C=C1 WKEWHSLZDDZONF-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000008134 glucuronides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002896 organic halogen compounds Chemical class 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229910052615 phyllosilicate Inorganic materials 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940116905 potassium ascorbyl tocopheryl phosphate Drugs 0.000 description 1
- VIHIKSJKXIMMLV-FZTHFCCHSA-M potassium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] phosphate Chemical compound [K+].C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OP([O-])(=O)OC1=C(O)[C@@H]([C@@H](O)CO)OC1=O VIHIKSJKXIMMLV-FZTHFCCHSA-M 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 150000003342 selenium Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- LMEWRZSPCQHBOB-UHFFFAOYSA-M silver;2-hydroxypropanoate Chemical compound [Ag+].CC(O)C([O-])=O LMEWRZSPCQHBOB-UHFFFAOYSA-M 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 229940035024 thioglycerol Drugs 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- ZFNVDHOSLNRHNN-UHFFFAOYSA-N xi-3-(4-Isopropylphenyl)-2-methylpropanal Chemical compound O=CC(C)CC1=CC=C(C(C)C)C=C1 ZFNVDHOSLNRHNN-UHFFFAOYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 1
- 229940100530 zinc ricinoleate Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
Definitions
- the present application relates to aqueous-ethanolic cosmetic deodorants used in metallic containers, i. in particular containers with metallic inner surface or elements that are in contact with the deodorant, filled and stored without significant corrosion occurs.
- washing, cleansing and caring for one's own body is a fundamental human need, and modern industry is constantly trying to meet these needs of man in a variety of ways. Especially important for daily hygiene is the permanent elimination or at least reduction of body odor.
- Numerous specific deodorant or antiperspirant personal care products are known in the art which have been developed for use in body regions having a high density of sweat glands, especially in the underarm area. These are formulated in a wide variety of dosage forms, for example as powder, in stick form, as aerosol spray, pump spray, liquid and gel roll on application, cream, gel and as a soaked flexible substrate (towels).
- Cosmetic compositions especially deodorants and antiperspirants, usually contain at least one oil or one fatty substance and in any case always a fragrance component or a perfume.
- Ethanol is a preferred solvent in deodorants as it provides a cool and fresh-to-dry sensation to the skin when applied to the skin.
- the preferred form of application here are aerosols.
- high purity 99.5 to 100% ethanol (200 proof) ethanol is often used.
- water-based ethanol of 95 to 99.5% (190 proof) may cause corrosion.
- high-purity ethanol is not always commercially available and, compared to water-containing ethanol, more expensive to produce and therefore also more expensive.
- Electrolytes Active substances to prevent body odor are often electrolytes, e.g. Cocamidopropyl PG-Dimonium Chloride Phosphate, Silver Lactate, Zinc Ricinoleate, Aluminum Sulfate, Polyamino Biguanide Stearate etc.
- ethanol-containing preparations with water contents of z. B. 1 to 5 wt .-% and over more than 24h lasting effect against body odor without risk of corrosion in metal aerosol containers can be stored if the electrical conductivity of the preparation is less than 50 ⁇ / ⁇ and at least two different alcohols or polyols with 8 or more carbon atoms are contained as deodorant agents in a total concentration of at least 0.5 wt .-%.
- the present application thus provides:
- a deodorant cosmetic agent in a container which has at least one metallic surface area in contact with the cosmetic agent during storage or dosage of the cosmetic agent and / or at least one metallic component in contact with the cosmetic agent, the cosmetic agent containing :
- the cosmetic agent has an electrical conductivity of 50 ⁇ / ⁇ or less.
- Cosmetic composition according to item 1 wherein the container is a metal aerosol spray container.
- a cosmetic composition according to item 1 or 2 wherein the aliphatic alcohol compounds are selected from the group consisting of a saturated aliphatic compound having one or more 1,2-alkanediol group (s) and a monohydric alcohol.
- Cosmetic agent according to one of the preceding points wherein the compound having one or more 1, 2-alkanediol group (s) a linear or branched 1, 2-alkanediol having 8 to 12 carbon atoms, a linear or branched 1, 2-alkane diol ethers 8 to 30 carbon atoms and / or a linear or branched 1, 2-alkanediol ester having 8 to 30 carbon atoms.
- the 1, 2-alkanediol is 1, 2-octanediol and / or 1, 2-decanediol.
- 1, 2-alkanediol ether is an a- monoalkyl glycerol ether having a branched or linear saturated or unsaturated C 8 -C 22 alkyl radical, preferably ⁇ - (2-ethylhexyl) glycerol ether.
- composition according to one of the preceding points wherein the 1, 2-alkanediol ester is a carboxylic acid ester of mono-, di- and / or triglycerol, preferably glycerol monocaprylate (INCI: glyceryl caprylates), glycerol dicaprylates (INCI: polyglyceryl 2-caprylates) and / or glycerol tricaprylates (INCI: polyglyceryl 3-caprylates).
- Cosmetic composition according to item 8 wherein the monohydric alcohol is 2-methyl-5-cyclohexylpentanol.
- composition according to one of the preceding claims, wherein the agent further comprises one or more of the following compounds: phenoxyethanol, one or more tropolones, triethyl citrate.
- composition according to one of the preceding claims, wherein the agent contains as deodorant active ingredient 1, 2-octanediol and further 1, 2-hexanediol.
- a cosmetic agent which 0, 1 to 5.0 wt .-% water, ethanol and 0.1 to 5.0 wt .-% of at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms as deodorant agents contains, and which has an electrical conductivity of 50 ⁇ / ⁇ or less, as the content of a container such that at least one metallic surface area and / or at least one metallic component of the container is in contact with the cosmetic agent during storage or dosage of the cosmetic product , 14.
- a method for non-therapeutic, cosmetic deodorant treatment of the body wherein the deodorant described in any one of items 1 to 12 from the container on the skin, in particular the skin of the armpits, is applied.
- a process for the preparation of a deodorant cosmetic agent in the form of an aerosol which comprises using a cosmetic agent which contains 0, 1 to 5.0% by weight of water, ethanol and 0, 1 to 5.0% by weight. containing at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms as deodorant agents, and having an electrical conductivity of 50 ⁇ / ⁇ or less, optionally together with a blowing agent, fills in an aerosol spray container, which at least one metallic surface area and / or at least one metallic component which is in contact with the cometic agent upon storage or dosage of the cosmetic composition.
- all containers are suitable according to the invention as a container, which have a surface at risk of corrosion of a corrosion-prone component, that is, for example, a surface or a component made of aluminum or tinplate.
- Inventive agents are preferably packaged for use as aerosol, that is, they are packaged in a pressure vessel, from which they can be sprayed by means of a propellant.
- the packaging in other dosage forms, such as in a deodorant scooter with metallic inner surface, but is also included according to the invention.
- the agents according to the invention are in liquid or viscous, flowable form.
- the application is preferably carried out with spray devices. These spraying devices contain in a container a filling of the liquid, viscous-flowable or suspensionsformigen deodorant according to the invention.
- the filling is usually under the pressure of a propellant (compressed gas cans, aerosols, aerosols).
- the containers have a removal device, preferably in the form of valves, which allow the removal of the contents as fog, smoke, foam, powder, paste or liquid jet.
- a container for the sprayers are mainly cylindrical vessels made of metal (aluminum, tinplate, volume preferably a maximum of 1000 ml) in question.
- Creamy, gelatinous, pastose and liquid agents may be packaged, for example, in pump, spray or squeeze dispensers, in particular also in multi-chamber pumping, multi-chamber spray or multi-chamber Quetschspendern.
- the packaging for the compositions according to the invention may be opaque, but also transparent or translucent.
- liquid also includes any solid dispersions in liquids.
- Compositions according to the invention may also be present as pastes, ointments, lotions or creams.
- Solid funds can be present as a loose powder, pressed powder or as a pen.
- the application can also be carried out with a roller applicator, as described e.g. is known from the field of deodorant scooters.
- a roller applicator as described e.g. is known from the field of deodorant scooters.
- Such scooters have a ball mounted in a ball bed which can be moved by movement over a surface. The ball absorbs some of the agent to be distributed and conveys this to the surface to be treated.
- the agents according to the invention may also be multiphase, the phases may e.g. horizontally, so one above the other, or vertically, so next to each other, be arranged. It may also be a disperse system in which e.g. the solid constituents are distributed inhomogeneously in the liquid matrix, so that such a dispersed system should be shaken before use.
- composition according to the invention are used synonymously in the present application.
- normal conditions are a temperature of 20 ° C. and a pressure of 1013.25 mbar. Melting point data likewise relate to a pressure of 1013.25 mbar.
- compositions according to the invention comprise as cosmetically acceptable carriers 0, 1 to 5.0% by weight of water, preferably 0.5 to 5.0% by weight of water, and ethanol.
- the cosmetically acceptable carrier is from 0.1 to 5.0% by weight of water and ethanol. Accordingly, according to the invention there is the great advantage that ethanol which is commercially available as a cosmetically acceptable carrier and having a water content of from 0.5 to 5.0% by weight can preferably be used.
- Agents preferred according to the invention, such as ethanol-based deodorant sprays preferably contain from 1.0 to 4.5% by weight, also preferably from 1.5 to 4.0% by weight, more preferably from 2.5 to 4.0% by weight.
- % free that is, not molecularly bound, water, with the quantities given refer to the weight of the composition, without taking into account any existing propellant.
- the content of water of crystallization, water of hydration or similar molecularly bound water, which is contained in the constituents used, does not constitute free water in the sense of the present application.
- the cosmetic agent contains as a cosmetically acceptable carrier 96% ethanol in an amount of 60 to 97 wt.%, More preferably 70 to 95 wt .-%, further preferably 80 to 90 wt .-%, wherein the wt .-% - refer to the total weight of the composition, without taking into account any existing propellant.
- the cosmetically acceptable carrier may comprise further components, for example a cosmetic oil which is liquid under standard conditions and which is not a fragrance and is not an essential oil, and talcum and mixtures thereof. Under normal conditions liquid cosmetic oils are immiscible with water. As far as in the present application of a cosmetic oil is mentioned, this is always a cosmetic oil that is not a fragrance and no essential oil, is liquid under normal conditions and immiscible with water.
- compositions according to the invention are present as deodorants and contain as nonionic deodorant active ingredient at least two saturated aliphatic alcohol compounds having 8 or more carbon atoms in a total amount of 0.1-5.0% by weight, preferably 0.2-3.0% by weight. %, more preferably 0.3-2.0% by weight, also preferably 0.5-1.5% by weight, and most preferably 0.7-1.0% by weight, wherein the weight percentages % Information on the total weight of the composition, without taking into account any existing propellant.
- ethanol does not count as a deodorant active ingredient, but, if present, only as a constituent of the carrier.
- deodorant actives contain at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms in a proportion of 0.1 to 5.0% by weight.
- the alcohols may be monohydric alcohols or polyols.
- the aliphatic alcohol compounds according to the invention are selected in particular from the group consisting of saturated aliphatic compounds with one or more 1, 2-alkanediol group (s) and monohydric alcohols.
- the compound having one or more 1,2-alkanediol group (s) is preferably a linear or branched 1,2-alkanediol having 8 to 12 carbon atoms, a linear or branched 1, 2 Alkandiolether having 8 to 30 carbon atoms and / or a linear or branched 1, 2-alkanediol ester having 8 to 30 carbon atoms.
- the 1,2-alkanediol is preferably a linear 1, 2-alkanediol having 8 to 12 carbon atoms, which is described by the formula HO-CH 2 -CH (OH) - (CH 2) n -CH 3 , in which n is the numbers 5, 6, 7, 8 or 9, as well as mixtures of these 1, 2-alkanediols.
- 1, 2-alkanediols having 8 to 12 C atoms which are particularly preferred according to the invention are selected from 1,2-octanediol, 1,2-decanediol and mixtures thereof.
- n is the number 5, 6, 7, 8 or 9 is one or more further alkanediols having 5 to 7 carbon atoms, in particular 1, 2-pentanediol and / or 1, 2-hexanediol.
- mixtures of 1, 2-hexanediol and 1, 2-octanediol preferably in a weight ratio of 5: 1 to 1: 5, preferably in a weight ratio of about 1: 1 in the cosmetic composition.
- Such mixtures are commercially available, for example, under the name Symdiol® 68 (Symrise).
- Preferred agents according to the invention comprise the at least one 1,2-alkanediol having 8 to 12 C atoms, which is described by the formula HO-CH 2 -CH (OH) - (CH 2) n -CH 3, in which n represents the numbers 5, 6, 7, 8 or 9, in a total amount of 0, 1-3 wt .-%, more preferably 0.2 to 1 wt .-%, particularly preferably 0.2 to 0.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
- the 1,2-alkanediol ether is preferably an ⁇ -monoalkyl glycerol ether having a branched or linear saturated or unsaturated C 8 -C 22 -alkyl radical.
- a preferred such 1, 2-alkanediol ether is ⁇ - (2-ethylhexyl) glycerol ether, commercially available as Sensiva® SC 50 (ex Schülke & Mayr).
- the 1,2-alkanediol ether is preferably contained in an amount of 0.2 to 1.0% by weight in the cosmetic composition, more preferably 0.3 to 0.5% by weight.
- the linear or branched 1,2-alkanediol ester as deodorant active ingredient is preferably a carboxylic acid ester of mono-, di- or triglycerol.
- these are glycerol monolaurate, diglycerol monocaprate, triglycerol acrylate, diglyceryl acrylate and glycerol acrylate, of which triglyceryl acrylate (eg Tego® Cosmo P813, Evonik), diglycerol acrylate (eg Dermosoft® GMCY, Dr. Straetmans) and glycerol acrylate (eg Dermosoft® DGMC, Dr.
- triglyceryl acrylate eg Tego® Cosmo P813, Evonik
- diglycerol acrylate eg Dermosoft® GMCY, Dr. Straetmans
- glycerol acrylate eg Dermosoft® DGMC, Dr.
- the 1,2-alkanediol ester is preferably present in an amount of 0.05 to 1.0% by weight in the cosmetic composition, furthermore preferably 0.1 to 0.5% by weight, and also preferably 0.2 to 0 , 3% by weight.
- the monohydric alcohol as the deodorant active is preferably a linear or branched alcohol having 8 to 30 carbon atoms, more preferably 8 to 12 carbon atoms, having a terminal OH group. Furthermore, the monohydric alcohol preferably has an alicyclic ring.
- a preferred example of such a deodorant active ingredient is 2-methyl-5-cyclohexylpentanol, commercially available, for example, as SymDeo® B125 (Symrise).
- the monohydric alcohol is preferably contained in an amount of 0.1 to 1.0% by weight in the cosmetic composition, further preferably 0.2 to 0.8% by weight, also preferably 0.3 to 0.7% by weight .-%.
- the electrical conductivity of the cosmetic composition is 50 ⁇ / ⁇ or less.
- maintaining the value of the electric conductivity of 50 ⁇ / ⁇ or less alone is not enough to sufficiently reduce corrosion. It has been surprisingly found in the present invention, however, that this value or lower values of electrical conductivity in combination with the use of said nonionic deodorant agents in a concentration of at least 0.5 wt .-% of the occurrence of corrosion in containers with metallic surfaces and / or components that are in contact with the composition reliably and permanently prevented.
- the value of the electrical conductivity was determined in the present invention using the Condhmometer 856 from Metrohm.
- the electrical conductivity of the cosmetic composition is according to the invention 0 to 50 ⁇ / ⁇ , preferably 20 to 45 ⁇ / ⁇ , more preferably 30 to 40 ⁇ / ⁇ .
- the agents according to the invention comprise as further deodorizing agent at least one aromatic alcohol of structure (AA-1), R 5 R 3 R 1
- the radicals R to R 6 independently of one another represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, which may be linear or branched and substituted with OH groups or alkoxy groups having 1 to 5 carbon atoms,
- radicals R 7 to R independently of one another are a hydrogen atom, a halogen atom, in particular a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, in particular with a methoxy group,
- n, o, p are independently integers from 0 to 10, with at least one of the values n, o, p ⁇ 0.
- Particularly preferred products according to the invention contain at least one alcohol AA-1, as described above, which is selected from phenoxyethanol, anisalcohol, 2-methyl-5-phenylpentan-1-ol, 1, 1-dimethyl-3-phenylpropane 1-ol, benzyl alcohol, 2-phenylethan-1-ol, 3-phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptan-1-ol, 2, 2-Dimethyl-3-phenyl-propan-1-ol, 2,2-dimethyl-3- (3'-methyl-phenyl) -propan-1-ol, 2-ethyl-3-phenylpropan-1-ol, 2-ethyl -3- (3'-methylphenyl) -propan-1-ol, 3- (3'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (2'-chlorophenyl) -2
- compositions according to the invention comprise at least one alcohol AA-1, as described above, in a total amount of 0.05-10% by weight, preferably 0.1-1.5% by weight, more preferably 0.2-2% by weight .-%, most preferably 0.3 to 1, 5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
- the cosmetic composition may furthermore comprise as further deodorant active ingredient at least one compound from the group of tropolones (I)
- very particularly preferred tropolones are the alpha-tropolone and the three isomeric thujaplicins.
- Preferred uses according to the invention are characterized in that the or the 1,2-alkanediol (s) together with at least one compound from the group
- the cosmetic composition particularly preferably contains tropolone (2-hydroxy-2,4,6-cycloheptatrienone), preferably in an amount of 0.001-0.1% by weight, based on the weight of the composition, without taking into account any propellant present ,
- agents according to the invention are characterized by a content of the deodorant active ingredient triethyl citrate.
- Triethyl citrate is a known deodorant active which acts as an enzyme inhibitor for esterases and lipases and thus contributes to the broad spectrum effect of agents according to the invention.
- Preferred agents according to the invention contain from 0.5 to 15% by weight, preferably from 3 to 8% by weight, most preferably from 4 to 7% by weight, based in each case on the weight of the composition, without taking into account any blowing agent present.
- the cosmetic composition may further contain, as an antibacterial deodorant active ingredient, tea tree oil which is commercially available as Melalleuca Alternifolia Leaf Oil, for example as Melafresh® T96 from Southern Cross Botanicals.
- tea tree oil which is commercially available as Melalleuca Alternifolia Leaf Oil, for example as Melafresh® T96 from Southern Cross Botanicals.
- the amount thereof is preferably 0.01 to 0.5 wt .-%, more preferably 0.05 to 0.2 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
- Apocrine sweat is a complex mixture that includes sebum and other fats as well as steroids.
- Steroids themselves are not water soluble. In order to be carried away with the body fluids, they are usually present as sulfate or as glucuronide.
- On the Skin is the cleavage of these steroid esters in the volatile free steroids by hydrolytic enzymes of the skin bacteria, especially the coryneform bacteria. In principle all bacterial exoesterases are capable of this, but especially the enzymes arylsulfatase and beta-glucuronidase. Compounds which inhibit arylsulfatase or beta-glucuronidase therefore represent preferred deodorant active ingredients according to the invention.
- Corynebacterium A both short - chain C2 - Cs fatty acids and medium chain C6 - Ci2 fatty acids are formed, which are mainly responsible for the axillary body odor.
- all bacterial exoesterases are capable of this lipid cleavage, but especially the enzyme lipase.
- Compounds which inhibit lipase are therefore also preferred deodorant agents according to the invention.
- Another class of compounds which also results from the bacterial decomposition of the sweat constituents and which contributes to body odor are saturated and unsaturated aldehydes, especially those with a chain length of C6-C12, in particular hexanal, heptanal, octenal and nonenal. These are formed by beta-cleavage from the hydroperoxides, which are formed by the action of the 5-lipoxygenase on unsaturated fatty acids. Compounds which inhibit the enzyme 5-lipoxygenase are therefore also preferred deodorant agents according to the invention.
- VSC volatile sulfur compounds released by enzymatic reaction
- Sulfur-containing compounds come as water-soluble amino acid conjugates with sweat on the human skin They are released by enzymatic reactions from skin bacteria (especially staphylococci and corynebacteria), an enzyme that plays a key role in the release of VSCs, cystathionine beta-lyase, which cleaves VSCs from the amino acids and thus is an important cause in the development of body odor compounds which inhibit the enzyme cystathionine beta-lyase, therefore, also according to the invention are preferred deodorant agents.
- compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme arylsulfatase.
- preferred Deodorant active ingredients which act as arylsulfatase inhibitors are those disclosed in US 5643559, US 5676937, WO2001 / 099376 A2, EP1430879 A1 and DE 10216368 A1.
- agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme arylsulfatase, in a total amount of 0.001-10 wt.%, Preferably 0.01-5 wt.%, Particularly preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
- Further preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme beta-glucuronidase.
- Deodorant active ingredients which are active according to the invention and act as a beta-glucuronidase inhibitor are those disclosed in WO2003 / 039505 A2.
- Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme beta-glucuronidase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, more preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
- compositions according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme lipase.
- preferred deodorant active ingredients which act as lipase inhibitor are selected from those disclosed in EP 1428520 A2, further selected from the aminomethylenemalonic acid derivatives according to DE 3018132 A1, the ethylene oxide-propylene oxide copolymers according to GB 2335596 A1 and the salts of Phytic acid according to EP 650 720 A1.
- agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme lipase, in a total amount of 0.001-10 wt.%, Preferably 0.01-5 wt.%, Particularly preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
- agents according to the invention are characterized by a content of at least one compound which is an inhibitor of 5-lipoxygenase.
- Deodorant active ingredients which are preferred according to the invention and act as 5-lipoxygenase inhibitors are disclosed in EP 1428519 A2.
- Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme 5-lipoxygenase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, more preferably 0.1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
- agents according to the invention are characterized by a content of at least one compound that is an inhibitor of the enzyme cystathionine beta-lyase.
- Deodorant active ingredients which are preferred according to the invention and act as inhibitors of cystathionine beta-lyase are selected from those disclosed in EP 495918 B1, WO 2006/079934, DE 10201000046 A1, WO2010 / 031657 A1 and WO2010 / 046291 A1.
- agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme cystathionine beta-lyase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, particularly preferably 0.1-2.5% by weight, based in each case on the weight of the composition, of any propellant which may be present.
- deodorant active ingredients are odor absorbers, deodorizing ion exchangers, antimicrobial agents, prebiotic components and enzyme inhibitors or, more preferably, combinations of said active ingredients.
- Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention.
- silicates particularly preferred according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum.
- Other preferred odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably in a total amount of 0.1 to 10 wt .-%, more preferably 0.5 to 7 wt .-% and most preferably 1-5 wt .-%, each based on the total composition without propellant, included.
- germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
- These organisms include, among others, various species from the group of staphylococci, the group of Corynebacteria, anaerococci and micrococci.
- germ-inhibiting or antimicrobial agents are particularly preferred organohalogen compounds and halides and a number of plant extracts and. These include u. a. Triclosan, chlorhexidine and 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol. Furthermore, phenol, terpene alcohols such. As farnesol and chlorophyllin copper complexes preferred deodorant agents.
- Preferred deodorant compositions according to the invention contain as further constituent at least one deodorant active ingredient which is selected from aromatic alcohols of structure AA-1 with the abovementioned substituents, preferably phenoxyethanol, 1,2-alkanediols having 5 to 7 carbon atoms, tropolone, triethyl citrate and Mixtures thereof.
- deodorant active ingredient selected from aromatic alcohols of structure AA-1 with the abovementioned substituents, preferably phenoxyethanol, 1,2-alkanediols having 5 to 7 carbon atoms, tropolone, triethyl citrate and Mixtures thereof.
- Antioxidant substances can counteract the oxidative decomposition of the welding components and in this way inhibit odor development.
- Preferred antioxidants are imidazole and Imidazole derivatives (eg, urocanic acid), peptides, such as. B.
- D, L-carnosine, D-carnosine, L-carnosine and their derivatives eg., Anserin
- carotenoids eg., carotenes (eg, ⁇ -carotene, ß-carotene, lycopene) and their derivatives, lipoic acid and their derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thio compounds (eg thioglycerol, thiosorbitol, thioglycolic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl , Propyl, amyl, butyl, lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiod
- Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, in particular tocopheryl acetate (vinylamine acetate), and carotenoids, as well as butylhydroxytoluene and butylhydroxyanisole.
- compositions according to the invention which are in the form of an emulsion or suspension preferably also contain at least one liquid under normal conditions, which is not a fragrance and is not an essential oil.
- the cosmetic oil is liquid under normal conditions.
- Essential oils according to the invention are understood to mean mixtures of volatile components which are prepared by steam distillation from vegetable raw materials, such as. B. citrus oils.
- Particularly preferred deodorant or antiperspirant compositions according to the invention also contain at least one perfume.
- the definition of a fragrance in the sense of the present application is in accordance with the expert definition as it can be found in the R ⁇ MPP Chemie Lexikon, as of December 2007. Thereafter, a fragrance is a chemical compound with odor and / or taste that excites the hair cell receptors of the olfactory system (adequate stimulus).
- the necessary physical and chemical properties are a low molecular weight of at most 300 g / mol, a high vapor pressure, minimal water and high lipid solubility and weak polarity and the presence of at least one osmophoric group in the molecule.
- fragrances according to the invention have a molecular weight from 74 to 300 g / mol, contain at least one osmophoric group in the molecule and have an odor and / or taste, that is, they excite the hair cell receptors of the olfactory system.
- perfumes perfumes, perfume oils or perfume oil ingredients can be used.
- perfume oils or fragrances can according to the invention individual fragrance compounds, eg.
- ethers, aldehydes, ketones, alcohols and hydrocarbons e.g.
- Fragrance compounds of the ester type are known e.g.
- the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g.
- the linear alkanals of 8 - 18 C atoms citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones e.g. the ionones, alpha-lsomethylionone and methylcedryl ketone, the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance.
- Particularly preferred deodorant or antiperspirant compositions according to the invention contain at least one perfume in a total amount of 0.00001 to 10 wt .-%, preferably 0.5 to 7 wt .-%, most preferably 1-6 wt .-%, each based on the total weight of the agent, without taking into account any existing propellant.
- composition of some preferred cosmetic agents can be found in the following tables (figures in% by weight based on the total weight of the cosmetic composition, if not stated otherwise, without taking into account any possibly used propellant).
- Triethyl citrate 0.5 to 15.0 1, 0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
- 1,2-alkanediol ester with 8 0.05 to 1.0 0.1 to 1.0 0.1 to 0.5 0.2 to 0.4 0.2 to 0.3 to 30 carbon atoms
- 1,2-Alkandiolether with 8 0.05 to 2.0 0.1 to 1.5 0.2 to 1.0 0.3 to 0.7 0.3 to 0.5 to 30 carbon atoms
- Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
- 1,2-octanediol 0.05 to 3.0 0.1 to 2.0 0.15 to 0.2 to 0.7 0.2 to 0.5
- Triglyceryl acrylate 0.05 to 1.0 0.1 to 1.0 0.1 to 0.5 0.2 to 0.4 0.2 to 0.3 diglyceryl acrylate
- Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
- 1,2-octanediol 0.05 to 3.0 0.1 to 2.0 0.15 to 0.2 to 0.7 0.2 to 0.5
- Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
- 1,2-alkanediol ester with 8 0.05 to 1.0 0.1 to 1.0 0.1 to 0.5 0.2 to 0.4 0.2 to 0.3 to 30 carbon atoms
- 1,2-Alkandiolether with 8 0.05 to 2.0 0.1 to 1.5 0.2 to 1.0 0.3 to 0.7 0.3 to 0.5 to 30 carbon atoms
- Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
- Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
- Me is to be understood as meaning ethanol as a cosmetic carrier, and possibly further customary constituents of deodorants.
- compositions 1 to 6 were in this case in a weight ratio of 1: 3 with the propellant propane / butane (15/85) in epoxy-coated aluminum cans (varnish: PPG7940) filled with valve plate made of tinplate.
- Sprayable deodorants (in% by weight)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to aqueous-ethanolic cosmetic deodorants which are filled into and stored in metal containers, i.e. in particular containers having metal inner surfaces or elements that are in contact with the deodorant, without appreciable corrosion taking place.
Description
„Elektrolytarme Zubereitungen gegen Körpergeruch" "Low-electrolyte preparations against body odor"
Die vorliegende Anmeldung betrifft wässrig-ethanolische kosmetische Deodorants, die in metallischen Behältern, d.h. insbesondere Behältern mit metallischer Inneroberfläche oder Elementen, die mit dem Deodorant in Kontakt sind, abgefüllt und gelagert werden, ohne dass eine nennenswerte Korrosion auftritt. The present application relates to aqueous-ethanolic cosmetic deodorants used in metallic containers, i. in particular containers with metallic inner surface or elements that are in contact with the deodorant, filled and stored without significant corrosion occurs.
Das Waschen, Reinigen und Pflegen des eigenen Körpers stellt ein menschliches Grundbedürfnis dar, und die moderne Industrie versucht fortlaufend, diesen Bedürfnissen des Menschen in vielfältiger Weise gerecht zu werden. Besonders wichtig für die tägliche Hygiene ist die anhaltende Beseitigung oder zumindest Reduzierung des Körpergeruchs. Im Stand der Technik sind zahlreiche spezielle deodorierende oder schweißhemmende Körperpflegemittel bekannt, die für die Anwendung in Körperregionen mit einer hohen Dichte von Schweißdrüsen, insbesondere im Achselbereich, entwickelt wurden. Diese sind in den unterschiedlichsten Darreichungsformen konfektioniert, beispielsweise als Puder, in Stiftform, als Aerosolspray, Pumpspray, flüssige und gelförmige Roll on- Applikation, Creme, Gel und als getränktes flexibles Substrat (Deotücher). Washing, cleansing and caring for one's own body is a fundamental human need, and modern industry is constantly trying to meet these needs of man in a variety of ways. Especially important for daily hygiene is the permanent elimination or at least reduction of body odor. Numerous specific deodorant or antiperspirant personal care products are known in the art which have been developed for use in body regions having a high density of sweat glands, especially in the underarm area. These are formulated in a wide variety of dosage forms, for example as powder, in stick form, as aerosol spray, pump spray, liquid and gel roll on application, cream, gel and as a soaked flexible substrate (towels).
Kosmetische Zusammensetzungen, insbesondere Deodorantien und Antitranspirantien, enthalten meistens mindestens ein Öl oder eine Fettsubstanz und auf jeden Fall immer eine Riechstoff kompo- nente bzw. ein Parfüm. Cosmetic compositions, especially deodorants and antiperspirants, usually contain at least one oil or one fatty substance and in any case always a fragrance component or a perfume.
Ethanol ist ein bevorzugtes Lösungsmittel in Deodorantien, da es bei der Anwendung auf der Haut ein kühles und frisch-tockenes Hautgefühl ermöglicht. Die bevorzugte Anwendungsform sind hier Aerosole. Zur Verbesserung der Kompatibilität von Deodorantzusammensetzungen mit Metallverpackungen, insbesondere bei Verwendung von Ventiltellern aus Weißblech, wird oft hochreiner Ethanol 99,5 bis 100% (200 proof) verwendet. Bei Verwendung von wasserhaltigem Ethanol von 95 bis 99,5 % (190 proof) kann es dagegen zu Korrosion kommen. Hochreiner Ethanol ist aber kommerziell nicht immer verfügbar und im Vergleich zu wasserhaltigem Ethanol aufwändiger in der Herstellung und daher auch hochpreisiger. Ethanol is a preferred solvent in deodorants as it provides a cool and fresh-to-dry sensation to the skin when applied to the skin. The preferred form of application here are aerosols. To improve the compatibility of deodorant compositions with metal packaging, particularly when using tinplate valve plates, high purity 99.5 to 100% ethanol (200 proof) ethanol is often used. On the other hand, using water-based ethanol of 95 to 99.5% (190 proof) may cause corrosion. However, high-purity ethanol is not always commercially available and, compared to water-containing ethanol, more expensive to produce and therefore also more expensive.
Das Korrosionsrisiko ist in Anwesenheit von Elektrolyten erwartungsgemäß deutlich erhöht. Bei Wirkstoffen zur Verhinderung von Körpergeruch handelt es sich oftmals um Elektrolyte, z.B. Cocamidopropyl PG-Dimonium Chloride Phosphate, Silberlaktat, Zinc Ricinoleate, Aluminium Sulfate, Polyamino Biguanid Stearate etc. As expected, the risk of corrosion is significantly increased in the presence of electrolytes. Active substances to prevent body odor are often electrolytes, e.g. Cocamidopropyl PG-Dimonium Chloride Phosphate, Silver Lactate, Zinc Ricinoleate, Aluminum Sulfate, Polyamino Biguanide Stearate etc.
Durch Verwendung nichtionischer Wirkstoffe zur Verhinderung von Körpergeruch, wie zum Beispiel Phenoxyethanol, Triethylcitrat oder 1 ,2-Alkandiolen, kann zwar die Elektrolytkonzentration niedriger gehalten werden, Korrosionsprobleme treten aber dennoch häufig auf.
Es wurde nun gemäß dieser Erfindung überraschend festgestellt, dass ethanolhaltige Zubereitungen mit Wasseranteilen von z. B. 1 bis 5 Gew.-% und einer über mehr als 24h anhaltenden Wirkung gegen Körpergeruch ohne Korrosionsrisiko in Metallaerosolbehältern gelagert werden können, wenn die elektrische Leitfähigkeit der Zubereitung kleiner als 50 μβ/ϋΐη ist und mindestens zwei unterschiedliche Alkohole oder Polyole mit 8 oder mehr Kohlenstoffatomen als Deodorant-Wirkstoffe in einer Gesamtkonzentration von mindestens 0,5 Gew.-% enthalten sind. By using nonionic agents to prevent body odor, such as phenoxyethanol, triethyl citrate or 1, 2-alkanediols, while the electrolyte concentration can be kept lower, but corrosion problems are still common. It has now surprisingly been found according to this invention that ethanol-containing preparations with water contents of z. B. 1 to 5 wt .-% and over more than 24h lasting effect against body odor without risk of corrosion in metal aerosol containers can be stored if the electrical conductivity of the preparation is less than 50 μβ / ϋΐη and at least two different alcohols or polyols with 8 or more carbon atoms are contained as deodorant agents in a total concentration of at least 0.5 wt .-%.
Durch die vorliegende Anmeldung wird somit bereitgestellt: The present application thus provides:
1. Ein deodorierendes kosmetisches Mittel in einem Behälter, der bei Lagerung oder Dosierung des kosmetischen Mittels mindestens einen mit dem kosmetischen Mittel in Kontakt stehenden metallischen Oberflächenbereich und/oder mindestens ein mit dem kosmetischen Mittel in Kontakt stehendes metallisches Bauteil aufweist, wobei das kosmetische Mittel enthält: 1. A deodorant cosmetic agent in a container which has at least one metallic surface area in contact with the cosmetic agent during storage or dosage of the cosmetic agent and / or at least one metallic component in contact with the cosmetic agent, the cosmetic agent containing :
- 0,1 bis 5,0 Gew.-% Wasser, 0.1 to 5.0% by weight of water,
- Ethanol - ethanol
- 0,1 bis 5,0 Gew.-% mindestens zweier verschiedener nichtionischer gesättigter aliphatischer Alkoholverbindungen mit 8 oder mehr Kohlenstoffatomen als Deodorant-Wirkstoffe, wobei sich die Gew.-%-Angaben jeweils auf das Gesamtgewicht des erfindungsgemäßen Mittels beziehen, ohne ggf. vorhandenes Treibmittel zu berücksichtigen, und 0.1 to 5.0% by weight of at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms as deodorant active ingredients, the weight percentages in each case referring to the total weight of the composition according to the invention, without to consider existing propellants, and
wobei das kosmetische Mittel eine elektrische Leitfähigkeit von 50 μβ/ϋΐη oder weniger aufweist. wherein the cosmetic agent has an electrical conductivity of 50 μβ / ϋΐη or less.
2. Kosmetisches Mittel nach Punkt 1 , wobei der Behälter ein Metallaerosolsprühbehälter ist. 2. Cosmetic composition according to item 1, wherein the container is a metal aerosol spray container.
3. Kosmetisches Mittel nach Punkt 1 oder 2, wobei die aliphatischen Alkoholverbindungen aus der Gruppe ausgewählt sind, bestehend aus einer gesättigten aliphatischen Verbindung mit einer oder mehreren 1 ,2-Alkandiolgruppe(n) und einem einwertigen Alkohol. 3. A cosmetic composition according to item 1 or 2, wherein the aliphatic alcohol compounds are selected from the group consisting of a saturated aliphatic compound having one or more 1,2-alkanediol group (s) and a monohydric alcohol.
4. Kosmetisches Mittel nach einem der vorhergehenden Punkte, wobei die Verbindung mit einer oder mehreren 1 ,2-Alkandiolgruppe(n) ein lineares oder verzweigtes 1 ,2-Alkandiol mit 8 bis 12 Kohlenstoffatomen, ein linearer oder verzweigter 1 ,2-Alkandiolether mit 8 bis 30 Kohlenstoffatomen und/oder ein linearer oder verzweigter 1 ,2-Alkandiolester mit 8 bis 30 Kohlenstoffatomen ist.
5. Kosmetisches Mittel nach einem der vorhergehenden Punkte, wobei das 1 ,2-Alkandiol 1 ,2- Octandiol und/oder 1 ,2-Decandiol ist. 4. Cosmetic agent according to one of the preceding points, wherein the compound having one or more 1, 2-alkanediol group (s) a linear or branched 1, 2-alkanediol having 8 to 12 carbon atoms, a linear or branched 1, 2-alkane diol ethers 8 to 30 carbon atoms and / or a linear or branched 1, 2-alkanediol ester having 8 to 30 carbon atoms. 5. Cosmetic agent according to one of the preceding points, wherein the 1, 2-alkanediol is 1, 2-octanediol and / or 1, 2-decanediol.
6. Kosmetisches Mittel nach einem der vorhergehenden Punkte, wobei der 1 ,2-Alkandiolether ein a- Monoalkylglycerinether mit einem verzweigten oder linearen gesättigten oder ungesättigten C8-C22- Alkylrest ist, bevorzugt α -(2-Ethylhexyl)glycerinether. 6. Cosmetic agent according to one of the preceding points, wherein the 1, 2-alkanediol ether is an a- monoalkyl glycerol ether having a branched or linear saturated or unsaturated C 8 -C 22 alkyl radical, preferably α - (2-ethylhexyl) glycerol ether.
7. Kosmetisches Mittel nach einem der vorhergehenden Punkte, wobei der 1 ,2-Alkandiolester ein Carbonsäureester des Mono-, Di- und/oder Triglycerins ist, bevorzugt Glycerinmonocaprylat (INCI:Glyceryl Caprylate), Glycerindicaprylate (INCI:Polyglyceryl 2-Caprylate) und/oder Glycerintricaprylate (INCI:Polyglyceryl 3-Caprylate). 7. Cosmetic composition according to one of the preceding points, wherein the 1, 2-alkanediol ester is a carboxylic acid ester of mono-, di- and / or triglycerol, preferably glycerol monocaprylate (INCI: glyceryl caprylates), glycerol dicaprylates (INCI: polyglyceryl 2-caprylates) and / or glycerol tricaprylates (INCI: polyglyceryl 3-caprylates).
8. Kosmetisches Mittel nach einem der vorhergehenden Punkte, wobei der einwertige Alkohol ein linearer oder verzweigter Alkohol mit 8 bis 30 Kohlenstoffatomen und einer endständigen OH-Gruppe ist, der bevorzugt einen alicyclischen Ring aufweist. A cosmetic composition according to any preceding item, wherein the monohydric alcohol is a linear or branched alcohol having 8 to 30 carbon atoms and a terminal OH group which preferably has an alicyclic ring.
9. Kosmetisches Mittel nach Punkt 8, wobei der einwertige Alkohol 2-Methyl-5-Cyclohexylpentanol ist. 9. Cosmetic composition according to item 8, wherein the monohydric alcohol is 2-methyl-5-cyclohexylpentanol.
10. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei das Mittel weiterhin eine oder mehrere der folgenden Verbindungen enthält: Phenoxyethanol, ein oder mehrere Tropolone, Triethylcitrat. 10. Cosmetic composition according to one of the preceding claims, wherein the agent further comprises one or more of the following compounds: phenoxyethanol, one or more tropolones, triethyl citrate.
1 1. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei das Mittel als Deodorant-Wirkstoff 1 ,2-Octandiol enthält und weiterhin 1 ,2-Hexandiol enthält. 1 1. Cosmetic composition according to one of the preceding claims, wherein the agent contains as deodorant active ingredient 1, 2-octanediol and further 1, 2-hexanediol.
12. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei das Mittel 0,5 bis 5,0 Gew.-% Wasser und 0,5 bis 5,0 Gew.-% der mindestens zwei aliphatischen Alkoholverbindungen mit 8 oder mehr Kohlenstoffatomen enthält. 12. A cosmetic composition according to any one of the preceding claims, wherein the agent contains 0.5 to 5.0 wt .-% water and 0.5 to 5.0 wt .-% of at least two aliphatic alcohol compounds having 8 or more carbon atoms.
13. Verwendung eines kosmetischen Mittels, welches 0, 1 bis 5,0 Gew.-% Wasser, Ethanol und 0,1 bis 5,0 Gew.-% mindestens zweier verschiedener nichtionischer gesättigter aliphatischer Alkoholverbindungen mit 8 oder mehr Kohlenstoffatomen als Deodorant-Wirkstoffe enthält, und welches eine elektrische Leitfähigkeit von 50 μβ/ϋΐη oder weniger aufweist, als Inhalt eines Behälters derart, dass bei Lagerung oder Dosierung des kosmetischen Mittels mindestens ein metallischer Oberflächenbereich und/oder mindestens ein metallisches Bauteil des Behälters mit dem kosmetischen Mittel in Kontakt steht.
14. Verfahren zur nicht-therapeutischen, kosmetischen deodorierenden Behandlung des Körpers, bei dem das in einem der Punkte 1 bis 12 beschriebene deodorierenden Mittel aus dem Behälter auf die Haut, insbesondere die Haut der Achselhöhlen, aufgetragen wird. 13. Use of a cosmetic agent which 0, 1 to 5.0 wt .-% water, ethanol and 0.1 to 5.0 wt .-% of at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms as deodorant agents contains, and which has an electrical conductivity of 50 μβ / ϋΐη or less, as the content of a container such that at least one metallic surface area and / or at least one metallic component of the container is in contact with the cosmetic agent during storage or dosage of the cosmetic product , 14. A method for non-therapeutic, cosmetic deodorant treatment of the body, wherein the deodorant described in any one of items 1 to 12 from the container on the skin, in particular the skin of the armpits, is applied.
15. Verfahren zur Herstellung eines deodorierenden kosmetischen Mittels in Form eines Aerosols, dadurch gekennzeichnet, dass man ein kosmetisches Mittel, welches 0, 1 bis 5,0 Gew.-% Wasser, Ethanol und 0, 1 bis 5,0 Gew.-% mindestens zweier verschiedener nichtionischer gesättigter aliphatischer Alkoholverbindungen mit 8 oder mehr Kohlenstoffatomen als Deodorant-Wirkstoffe enthält, und welches eine elektrische Leitfähigkeit von 50 μβ/ϋΐη oder weniger aufweist, gegebenenfalls zusammen mit einem Treibmittel, in einen Aerosolsprühbehälter füllt, welcher mindestens einen metallischen Oberflächenbereich und/oder mindestens ein metallisches Bauteil aufweist, der/das bei Lagerung oder Dosierung des kosmetischen Mittels mit dem kometischen Mittel in Kontakt ist. 15. A process for the preparation of a deodorant cosmetic agent in the form of an aerosol, which comprises using a cosmetic agent which contains 0, 1 to 5.0% by weight of water, ethanol and 0, 1 to 5.0% by weight. containing at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms as deodorant agents, and having an electrical conductivity of 50 μβ / ϋΐη or less, optionally together with a blowing agent, fills in an aerosol spray container, which at least one metallic surface area and / or at least one metallic component which is in contact with the cometic agent upon storage or dosage of the cosmetic composition.
Bezüglich bevorzugter Ausführungsformen des erfindungsgemäßen Verfahrens und der erfindunsgemäßen Verwendung gilt mutatis mutandis das zu den erfindungsgemäßen Mitteln Gesagte. With regard to preferred embodiments of the method according to the invention and the use according to the invention, what has been said about the agents according to the invention applies mutatis mutandis.
Grundsätzlich sind erfindungsgemäß als Behälter alle Behälter geeignet, die eine korrosionsgefährdete Oberfläche der ein korrosionsgefährdetes Bauteil aufweisen, also beispielsweise eine Oberfläche oder ein Bauteil aus Aluminium oder Weißblech. Basically, all containers are suitable according to the invention as a container, which have a surface at risk of corrosion of a corrosion-prone component, that is, for example, a surface or a component made of aluminum or tinplate.
Erfindungsgemäße Mittel sind bevorzugt zur Anwendung als Aerosol verpackt, das heißt, sie sind in einem Druckbehälter verpackt, aus dem sie mit Hilfe eines Treibmittels versprüht werden können. Die Verpackung in anderen Darreichungsformen, wie beispielsweise in einem Deo-Roller mit metallischer Innenoberfläche, ist erfindungsgemäß aber auch umfasst. In einer bevorzugten Ausführungsform liegen die erfindungsmäßen Mittel in flüssiger oder in viskoser, fließfähiger Form vor. Die Applikation erfolgt bevorzugt mit Sprühvorrichtungen. Diese Sprühvorrichtungen enthalten in einem Behälter eine Füllung aus dem erfindungsgemäßen flüssigen, viskos-fließfähigen oder suspensionsformigen deodorierenden Mittel. Die Füllung steht in der Regel unter dem Druck eines Treibmittels (Druckgasdosen, Druckgaspackungen, Aerosolpackungen). Die Behälter weisen eine Entnahmevorrichtung auf, bevorzugt in Gestalt von Ventilen, die die Entnahme des Inhalts als Nebel, Rauch, Schaum, Pulver, Paste oder Flüssigkeitsstrahl ermöglichen. Als Behälter für die Sprühvorrichtungen kommen vor allem zylindrische Gefäße aus Metall (Aluminium, Weißblech, Rauminhalt bevorzugt maximal 1000 ml) in Frage. Auch Behälter aus geschütztem bzw. nichtsplitterndem Glas oder Kunststoff (Rauminhalt bevorzugt maximal 220 ml) bzw. splitterndem Glas oder Kunststoff (Rauminhalt bevorzugt maximal 150 ml), die ein Bauteil oder eine Oberfläche aus Metall aufweisen, das/die einer Korrosion unterliegen kann, kommen in Frage. Cremeförmige, gelförmige, pastose und flüssige Mittel können z.B. in Pump-, Spray- oder Quetschspendern abgepackt sein, insbesondere auch in Mehrkammer-Pump-, Mehrkammer-Spray- oder Mehrkammer-
Quetschspendern. Die Verpackung für die erfindungsgemäßen Mittel kann undurchsichtig, aber auch transparent oder transluzent sein. Inventive agents are preferably packaged for use as aerosol, that is, they are packaged in a pressure vessel, from which they can be sprayed by means of a propellant. The packaging in other dosage forms, such as in a deodorant scooter with metallic inner surface, but is also included according to the invention. In a preferred embodiment, the agents according to the invention are in liquid or viscous, flowable form. The application is preferably carried out with spray devices. These spraying devices contain in a container a filling of the liquid, viscous-flowable or suspensionsformigen deodorant according to the invention. The filling is usually under the pressure of a propellant (compressed gas cans, aerosols, aerosols). The containers have a removal device, preferably in the form of valves, which allow the removal of the contents as fog, smoke, foam, powder, paste or liquid jet. As a container for the sprayers are mainly cylindrical vessels made of metal (aluminum, tinplate, volume preferably a maximum of 1000 ml) in question. Even containers made of protected or non-shattering glass or plastic (volume preferably up to 220 ml) or splintering glass or plastic (volume preferably up to 150 ml), which have a component or a surface made of metal, which / may be subject to corrosion coming in question. Creamy, gelatinous, pastose and liquid agents may be packaged, for example, in pump, spray or squeeze dispensers, in particular also in multi-chamber pumping, multi-chamber spray or multi-chamber Quetschspendern. The packaging for the compositions according to the invention may be opaque, but also transparent or translucent.
Unter den Begriff der Flüssigkeit fallen im Sinne der Erfindung auch jegliche Festkörperdispersionen in Flüssigkeiten. Erfindungsgemäße Mittel können auch als Pasten, Salben, Lotionen oder Cremes vorliegen. Feste Mittel können beispielsweise als loser Puder, gepresster Puder oder als Stift vorliegen. For the purposes of the invention, the term liquid also includes any solid dispersions in liquids. Compositions according to the invention may also be present as pastes, ointments, lotions or creams. Solid funds can be present as a loose powder, pressed powder or as a pen.
Die Applikation kann im Falle flüssiger oder niedrig- bis mittelviskoser Mittel auch mit einem Roller- Applikator erfolgen, wie er z.B. aus dem Bereich der Deo-Roller bekannt ist. Solche Roller weisen eine in einem Kugelbett gelagerte Kugel auf, die durch Bewegung über eine Oberfläche bewegt werden kann. Dabei nimmt die Kugel etwas von dem zu verteilenden Mittel auf und befördert dieses an die zu behandelnde Oberfläche. In the case of liquid or low to medium-viscosity agents, the application can also be carried out with a roller applicator, as described e.g. is known from the field of deodorant scooters. Such scooters have a ball mounted in a ball bed which can be moved by movement over a surface. The ball absorbs some of the agent to be distributed and conveys this to the surface to be treated.
Die erfindungsgemäßen Mittel, bevorzugt flüssigen Mittel, können auch mehrphasig sein, die Phasen können z.B. horizontal, also übereinander, oder vertikal, also nebeneinander, angeordnet sein. Es kann sich auch um ein disperses System handeln, bei dem z.B. die festen Bestandteile inhomogen in der flüssigen Matrix verteilt sind, so dass ein solches disperses System vor der Anwendung geschüttelt werden sollte. The agents according to the invention, preferably liquid agents, may also be multiphase, the phases may e.g. horizontally, so one above the other, or vertically, so next to each other, be arranged. It may also be a disperse system in which e.g. the solid constituents are distributed inhomogeneously in the liquid matrix, so that such a dispersed system should be shaken before use.
Es sei an dieser Stelle darauf hingewiesen, dass sich die Angabe Gew.-%, sofern es nicht anders angegeben ist, jeweils auf das Gesamtgewicht des erfindungsgemäßen Mittels bezieht, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. It should be noted at this point that the statement wt .-%, unless stated otherwise, in each case refers to the total weight of the agent according to the invention, without taking into account any existing propellant.
Die Begriffe„erfindungsgemäßes Mittel" und„erfindungsgemäße Zusammensetzung" werden in der vorliegenden Anmeldung synonym gebraucht. The terms "agent according to the invention" and "composition according to the invention" are used synonymously in the present application.
„Normalbedingungen" sind im Sinne der vorliegenden Anmeldung eine Temperatur von 20 °C und ein Druck von 1013,25 mbar. Schmelzpunktangaben beziehen sich ebenfalls auf einen Druck von 1013,25 mbar. For the purposes of the present application, "normal conditions" are a temperature of 20 ° C. and a pressure of 1013.25 mbar. Melting point data likewise relate to a pressure of 1013.25 mbar.
Die erfindungsgemäßen Mittel enthalten als kosmetisch verträglichen Träger 0, 1 bis 5,0 Gew.-% Wasser, bevorzugt 0,5 bis 5,0 Gew.-% Wasser, und Ethanol. In Ausführungsformen besteht der kosmetisch verträgliche Träger aus 0,1 bis 5,0 Gew.-% Wasser und Ethanol. Demgemäß ist erfindungsgemäß der große Vorteil gegeben, dass als kosmetisch verträglicher Träger im Handel erhältlicher Ethanol mit einem Wassergehalt von 0,5 bis 5,0 Gew.-% bevorzugt eingesetzt werden kann. Erfindungsgemäß bevorzugte Mittel, wie Ethanol-basierte Deodorantsprays, enthalten bevorzugter 1 ,0 - 4,5 Gew.-%, ebenfalls bevorzugt 1 ,5 - 4,0 Gew.-%, weiterhin bevorzugt 2,5 bis 4,0 Gew.-% freies, das heißt, nicht molekular gebundenes, Wasser, wobei sich die Mengenangaben
auf das Gewicht der Zusammensetzung beziehen, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Der Gehalt an Kristallwasser, Hydratationswasser oder ähnlich molekular gebundenem Wasser, der in den eingesetzten Bestandteilen, enthalten ist, stellt im Sinne der vorliegenden Anmeldung kein freies Wasser dar. The compositions according to the invention comprise as cosmetically acceptable carriers 0, 1 to 5.0% by weight of water, preferably 0.5 to 5.0% by weight of water, and ethanol. In embodiments, the cosmetically acceptable carrier is from 0.1 to 5.0% by weight of water and ethanol. Accordingly, according to the invention there is the great advantage that ethanol which is commercially available as a cosmetically acceptable carrier and having a water content of from 0.5 to 5.0% by weight can preferably be used. Agents preferred according to the invention, such as ethanol-based deodorant sprays, preferably contain from 1.0 to 4.5% by weight, also preferably from 1.5 to 4.0% by weight, more preferably from 2.5 to 4.0% by weight. % free, that is, not molecularly bound, water, with the quantities given refer to the weight of the composition, without taking into account any existing propellant. The content of water of crystallization, water of hydration or similar molecularly bound water, which is contained in the constituents used, does not constitute free water in the sense of the present application.
Gemäß bevorzugten Ausführungsformen der Erfindung enthält das kosmetische Mittel als kosmetisch verträglichen Träger 96 % Ethanol in einer Menge von 60 bis 97 Gew.%, bevorzugter 70 bis 95 Gew.-%, weiterhin bevorzugt 80 bis 90 Gew.-%, wobei sich die Gew.-%-Angaben auf das Gesamtgewicht der Zusammensetzung beziehen, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. According to preferred embodiments of the invention, the cosmetic agent contains as a cosmetically acceptable carrier 96% ethanol in an amount of 60 to 97 wt.%, More preferably 70 to 95 wt .-%, further preferably 80 to 90 wt .-%, wherein the wt .-% - refer to the total weight of the composition, without taking into account any existing propellant.
Erfindungsgemäß ist aber auch umfasst, dass der kosmetisch verträgliche Träger weitere Komponenten enthalten kann, beispielsweise ein unter Normalbedingungen flüssiges kosmetisches Öl, das kein Riechstoff und kein ätherisches Öl ist, und Talkum sowie Mischungen hiervon, umfasst. Die unter Normalbedingungen flüssigen kosmetischen Öle sind mit Wasser nicht mischbar. Sofern in der vorliegenden Anmeldung von einem kosmetischen Öl die Rede ist, handelt es sich hierbei immer um ein kosmetisches Öl, das kein Riechstoff und kein ätherisches Öl ist, unter Normalbedingungen flüssig und mit Wasser nicht mischbar ist. According to the invention, however, it is also included that the cosmetically acceptable carrier may comprise further components, for example a cosmetic oil which is liquid under standard conditions and which is not a fragrance and is not an essential oil, and talcum and mixtures thereof. Under normal conditions liquid cosmetic oils are immiscible with water. As far as in the present application of a cosmetic oil is mentioned, this is always a cosmetic oil that is not a fragrance and no essential oil, is liquid under normal conditions and immiscible with water.
Erfindungsgemäße Zusammensetzungen liegen als Deodorant vor und enthalten als nichtionischen Deodorant-Wirkstoff mindestens zwei gesättigte aliphatische Alkoholverbindungen mit 8 oder mehr Kohlenstoffatomen in einer Gesamtmenge von 0,1 - 5,0 Gew.-%, bevorzugt 0,2 - 3,0 Gew.-%, bevorzugter 0,3 - 2,0 Gew.-%, ebenfalls bevorzugt 0,5 - 1 ,5 Gew.-%, und am bevorzugtesten 0,7 - 1 ,0 Gew.-%, wobei sich die Gew.-%-Angaben auf das Gesamtgewicht der Zusammensetzung beziehen, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Compositions according to the invention are present as deodorants and contain as nonionic deodorant active ingredient at least two saturated aliphatic alcohol compounds having 8 or more carbon atoms in a total amount of 0.1-5.0% by weight, preferably 0.2-3.0% by weight. %, more preferably 0.3-2.0% by weight, also preferably 0.5-1.5% by weight, and most preferably 0.7-1.0% by weight, wherein the weight percentages % Information on the total weight of the composition, without taking into account any existing propellant.
Ethanol gilt erfindungsgemäß nicht als Deodorant-Wirkstoff, sondern, sofern vorhanden, nur als Bestandteil des Trägers. According to the invention, ethanol does not count as a deodorant active ingredient, but, if present, only as a constituent of the carrier.
Es ist für die vorliegende Erfindung wesentlich, dass als Deodorant-Wirkstoffe mindestens zwei verschiedene nichtionische gesättigte aliphatische Alkoholverbindungen mit 8 oder mehr Kohlenstoffatomen in einem Anteil von 0,1 bis 5,0 Gew.-% enthalten sind. Bei den Alkoholen kann es sich um einwertige Alkohole oder um Polyole handeln. It is essential to the present invention that deodorant actives contain at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms in a proportion of 0.1 to 5.0% by weight. The alcohols may be monohydric alcohols or polyols.
Die aliphatischen Alkoholverbindungen sind erfindungsgemäß insbesondere aus der Gruppe ausgewählt, bestehend aus gesättigten aliphatischen Verbindungen mit einer oder mehreren 1 ,2- Alkandiolgruppe(n) und einwertigen Alkoholen. The aliphatic alcohol compounds according to the invention are selected in particular from the group consisting of saturated aliphatic compounds with one or more 1, 2-alkanediol group (s) and monohydric alcohols.
Die Verbindung mit einer oder mehreren 1 ,2-Alkandiolgruppe(n) ist bevorzugt ein lineares oder verzweigtes 1 ,2-Alkandiol mit 8 bis 12 Kohlenstoffatomen, ein linearer oder verzweigter 1 ,2-
Alkandiolether mit 8 bis 30 Kohlenstoffatomen und/oder ein linearer oder verzweigter 1 ,2- Alkandiolester mit 8 bis 30 Kohlenstoffatomen. The compound having one or more 1,2-alkanediol group (s) is preferably a linear or branched 1,2-alkanediol having 8 to 12 carbon atoms, a linear or branched 1, 2 Alkandiolether having 8 to 30 carbon atoms and / or a linear or branched 1, 2-alkanediol ester having 8 to 30 carbon atoms.
Das 1 ,2-Alkandiol ist bevorzugt ein lineares 1 ,2-Alkandiol mit 8 bis 12 C-Atomen, welches durch die Formel HO-CH2-CH(OH)-(CH2)n-CH3 beschrieben wird, in der n für die Zahlen 5, 6, 7, 8 oder 9 steht, sowie Mischungen dieser 1 ,2-Alkandiole. Erfindungsgemäß besonders bevorzugte 1 ,2-Alkandiole mit 8 bis 12 C-Atomen sind ausgewählt aus 1 ,2-Octandiol, 1 ,2-Decandiol und Mischungen hiervon. The 1,2-alkanediol is preferably a linear 1, 2-alkanediol having 8 to 12 carbon atoms, which is described by the formula HO-CH 2 -CH (OH) - (CH 2) n -CH 3 , in which n is the numbers 5, 6, 7, 8 or 9, as well as mixtures of these 1, 2-alkanediols. 1, 2-alkanediols having 8 to 12 C atoms which are particularly preferred according to the invention are selected from 1,2-octanediol, 1,2-decanediol and mixtures thereof.
In einer bevorzugten Ausführungsform der Erfindung sind zusätzlich zu dem 1 ,2-Alkandiol mit der Formel HO-CH2-CH(OH)-(CH2)n-CH3, in der n für die Zahlen 5, 6, 7, 8 oder 9 steht, ein oder mehrere weitere Alkandiole mit 5 bis 7 Kohlenstoffatomen, insbesondere 1 ,2-Pentandiol und/oder 1 ,2- Hexandiol, enthalten. In a preferred embodiment of the invention, in addition to the 1,2-alkanediol having the formula HO-CH 2 -CH (OH) - (CH 2) n -CH 3 , in which n is the number 5, 6, 7, 8 or 9 is one or more further alkanediols having 5 to 7 carbon atoms, in particular 1, 2-pentanediol and / or 1, 2-hexanediol.
Beispielsweise sind Mischungen aus 1 ,2-Hexandiol und 1 ,2-Octandiol, vorzugsweise im Gewichtsverhältnis von 5:1 bis 1 :5, bevorzugt im Gewichtsverhältnis von etwa 1 :1 in der kosmetischen Zusammensetzung enthalten. Derartige Gemische sind im Handel beispielsweise under der Bezeichnung Symdiol® 68 (Symrise) erhältlich. For example, mixtures of 1, 2-hexanediol and 1, 2-octanediol, preferably in a weight ratio of 5: 1 to 1: 5, preferably in a weight ratio of about 1: 1 in the cosmetic composition. Such mixtures are commercially available, for example, under the name Symdiol® 68 (Symrise).
Bevorzugte erfindungsgemäße Mittel enthalten das mindestens ein 1 ,2-Alkandiol mit 8 bis 12 C- Atomen, das durch die Formel HO-CH2-CH(OH)-(CH2)n-CH3 beschrieben wird, in der n für die Zahlen 5, 6, 7, 8 oder 9 steht, in einer Gesamtmenge von 0, 1 - 3 Gew.-%, bevorzugter 0,2 - 1 Gew.-%, besonders bevorzugt 0,2 - 0,5 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Preferred agents according to the invention comprise the at least one 1,2-alkanediol having 8 to 12 C atoms, which is described by the formula HO-CH 2 -CH (OH) - (CH 2) n -CH 3, in which n represents the numbers 5, 6, 7, 8 or 9, in a total amount of 0, 1-3 wt .-%, more preferably 0.2 to 1 wt .-%, particularly preferably 0.2 to 0.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
Der 1 ,2-Alkandiolether ist erfindungsgemäß bevorzugt ein a-Monoalkylglycerinether mit einem verzweigten oder linearen gesättigten oder ungesättigten C8-C22-Alkylrest. Ein bevorzugter solcher 1 ,2-Alkandiolether ist α -(2-Ethylhexyl)glycerinether, im Handel erhältlich als Sensiva® SC 50 (ex Schülke & Mayr). Der 1 ,2-Alkandiolether ist bevorzugt in einer Menge von 0,2 bis 1 ,0 Gew.-% in der kosmetischen Zusammensetzung enthalten, weiterhin bevorzugt 0,3 bis 0,5 Gew.-%. According to the invention, the 1,2-alkanediol ether is preferably an α-monoalkyl glycerol ether having a branched or linear saturated or unsaturated C 8 -C 22 -alkyl radical. A preferred such 1, 2-alkanediol ether is α- (2-ethylhexyl) glycerol ether, commercially available as Sensiva® SC 50 (ex Schülke & Mayr). The 1,2-alkanediol ether is preferably contained in an amount of 0.2 to 1.0% by weight in the cosmetic composition, more preferably 0.3 to 0.5% by weight.
Der lineare oder verzweigte 1 ,2-Alkandiolester als Deodorant-Wirkstoff ist bevorzugt ein Carbonsäureester des Mono-, Di- oder Triglycerins. Beispiele hierfür sind Glycerinmonolaurat, Diglycerinmonocaprinat, Triglycerincaprylat, Diglycerincaprylat und Glycerincaprylat, wovon Triglycerincaprylat (z.B. Tego® Cosmo P813, Evonik), Diglycerincaprylat (z.B. Dermosoft® GMCY, Dr. Straetmans) und Glycerincaprylat (z.B. Dermosoft® DGMC, Dr. Straetmans) bevorzugt sind. Der 1 ,2-Alkandiolester ist bevorzugt in einer Menge von 0,05 bis 1 ,0 Gew.-% in der kosmetischen Zusammensetzung enthalten, weiterhin bevorzugt 0, 1 bis 0,5 Gew.-%, ebenfalls bevorzugt 0,2 bis 0,3 Gew.-%.
Der einwertige Alkohol als Deodorant-Wirkstoff ist bevorzugt ein linearer oder verzweigter Alkohol mit 8 bis 30 Kohlenstoffatomen, weiter bevorzugt 8 bis 12 Kohlenstoffatomen, der eine endständige OH-Gruppe aufweist. Weiterhin weist der einwertige Alkohol bevorzugt einen alicyclischen Ring auf. Ein bevorzugtes Beispiel eines derartigen Deodorant-Wirkstoffs ist 2-Methyl-5-cyclohexylpentanol, im Handel z.B. als SymDeo® B125 (Symrise) erhältlich. The linear or branched 1,2-alkanediol ester as deodorant active ingredient is preferably a carboxylic acid ester of mono-, di- or triglycerol. Examples of these are glycerol monolaurate, diglycerol monocaprate, triglycerol acrylate, diglyceryl acrylate and glycerol acrylate, of which triglyceryl acrylate (eg Tego® Cosmo P813, Evonik), diglycerol acrylate (eg Dermosoft® GMCY, Dr. Straetmans) and glycerol acrylate (eg Dermosoft® DGMC, Dr. Straetmans) are preferred , The 1,2-alkanediol ester is preferably present in an amount of 0.05 to 1.0% by weight in the cosmetic composition, furthermore preferably 0.1 to 0.5% by weight, and also preferably 0.2 to 0 , 3% by weight. The monohydric alcohol as the deodorant active is preferably a linear or branched alcohol having 8 to 30 carbon atoms, more preferably 8 to 12 carbon atoms, having a terminal OH group. Furthermore, the monohydric alcohol preferably has an alicyclic ring. A preferred example of such a deodorant active ingredient is 2-methyl-5-cyclohexylpentanol, commercially available, for example, as SymDeo® B125 (Symrise).
Der einwertige Alkohol ist bevorzugt in einer Menge von 0,1 bis 1 ,0 Gew.-% in der kosmetischen Zusammensetzung enthalten, weiterhin bevorzugt 0,2 bis 0,8 Gew.-%, ebenfalls bevorzugt 0,3 bis 0,7 Gew.-%. The monohydric alcohol is preferably contained in an amount of 0.1 to 1.0% by weight in the cosmetic composition, further preferably 0.2 to 0.8% by weight, also preferably 0.3 to 0.7% by weight .-%.
Ein weiteres wesentliches Merkmal der vorliegenden Erfindung ist, dass die elektrische Leitfähigkeit der kosmetischen Zusammensetzung 50 μβ/ϋΐη oder weniger beträgt. Die Verwendung oben genannter nichtionischer Deodorant-Wirkstoffe kann, neben einer Vermeidung anderer ionscher Bestandteile, zu einer niedrigen elektrischen Leitfähigkeit beitragen. Die Einhaltung des Werts der elektrischen Leitfähigkeit von 50 μβ/ϋΐη oder weniger allein reicht aber nicht aus, um eine Korrosion ausreichend zu vermindern. Es wurde im Rahmen der vorliegenden Erfindung aber überraschend festgestellt, dass dieser Wert oder niedrigere Werte der elektrischen Leitfähigkeit in Kombination mit der Verwendung der genannten nichtionischen Deodorant-Wirkstoffe in einer Konzentration von mindestens 0,5 Gew.-% das Auftreten von Korrosion in Behältern mit metallischen Oberflächen und/oder Bauteilen, die in Kontakt mit der Zusammensetzung sind, zuverlässig und dauerhaft verhindert. Another essential feature of the present invention is that the electrical conductivity of the cosmetic composition is 50 μβ / ϋΐη or less. The use of the above-mentioned nonionic deodorant active ingredients, in addition to avoiding other ionic components, contribute to a low electrical conductivity. However, maintaining the value of the electric conductivity of 50 μβ / ϋΐη or less alone is not enough to sufficiently reduce corrosion. It has been surprisingly found in the present invention, however, that this value or lower values of electrical conductivity in combination with the use of said nonionic deodorant agents in a concentration of at least 0.5 wt .-% of the occurrence of corrosion in containers with metallic surfaces and / or components that are in contact with the composition reliably and permanently prevented.
Der Wert der elektrischen Leitfähigkeit wurde in der vorliegenden Erfindung mit dem Conductometer 856 von Metrohm bestimmt. Als Sensor wurde die zugehörige Messzelle mit 5 Ringen (c = 1 ,0 cm"1) von Metrohm verwendet. Die Messungen erfolgten bei 23°C. The value of the electrical conductivity was determined in the present invention using the Condhmometer 856 from Metrohm. The measuring cell with 5 rings (c = 1, 0 cm "1 ) from Metrohm was used as the sensor and the measurements were carried out at 23 ° C.
Die elektrische Leitfähigkeit der kosmetischen Zusammensetzung ist erfindungsgemäß 0 bis 50 μβ/ϋΐη, bevorzugt 20 bis 45 μβ/ϋΐη, bevorzugter 30 bis 40 μβ/αη. The electrical conductivity of the cosmetic composition is according to the invention 0 to 50 μβ / ϋΐη, preferably 20 to 45 μβ / ϋΐη, more preferably 30 to 40 μβ / αη.
Neben den genannnten Bestandteilen der kosmetischen Zusammensetzung können weitere Bestandteile enthalten sein, insbesondere weitere Deodorant-Wirkstoffe. In addition to the genannnten constituents of the cosmetic composition further ingredients may be included, in particular further deodorant agents.
In einer bevorzugten Ausführungsform enthalten die erfindungsgemäßen Mittel als weiteren deodorierenden Wirkstoff mindestens einen aromatischen Alkohol der Struktur (AA-1 ),
R5 R3 R1 In a preferred embodiment, the agents according to the invention comprise as further deodorizing agent at least one aromatic alcohol of structure (AA-1), R 5 R 3 R 1
(- O -)— (~ C-)-( c )-(-C-)- OH (- O -) - ( - C -) - (c) - (- C -) - OH
m 0 p m 0 p
R6 R4 R2 R 6 R 4 R 2
R 7-1 1 R 7-1 1
(AA-1 ) (AA-1)
wobei in which
die Reste R bis R6 unabhängig voneinander ein Wasserstoffatom, eine Alkylgruppe mit 1 bis 10 Kohlenstoffatomen, die linear oder verzweigt und substituiert sein können mit OH-Gruppen oder Alkoxy-Gruppen mit 1 bis 5 Kohlenstoffatomen, oder eine Alkenylgruppe mit 2 bis 10 Kohlenstoffatomen, die linear oder verzweigt und substituiert sein können mit OH-Gruppen oder Alkoxy- Gruppen mit 1 bis 5 Kohlenstoffatomen, the radicals R to R 6 independently of one another represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, which may be linear or branched and substituted with OH groups or alkoxy groups having 1 to 5 carbon atoms,
die Reste R7 bis R unabhängig voneinander ein Wasserstoffatom, ein Halogenatom, insbesondere ein Chloratom, oder eine Alkylgruppe mit 1 bis 10 Kohlenstoffatomen, die linear oder verzweigt und substituiert sein können mit OH-Gruppen oder Alkoxy-Gruppen mit 1 bis 5 Kohlenstoffatomen, insbesondere mit einer Methoyxgruppe, the radicals R 7 to R independently of one another are a hydrogen atom, a halogen atom, in particular a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, in particular with a methoxy group,
m = 0 oder 1 ist, n, o, p = unabhängig voneinander ganze Zahlen von 0 bis 10 sind, wobei mindestens einer der Werte n, o, p Φ 0 ist. m = 0 or 1, n, o, p = are independently integers from 0 to 10, with at least one of the values n, o, p Φ 0.
Besonders bevorzugte erfindungsgemäße Produkte enthalten mindestens einen Alkohol AA-1 , wie vorstehend beschrieben, der ausgewählt ist aus Phenoxyethanol, Anisalkohol, 2-Methyl-5-phenyl- pentan-1-ol, 1 , 1-Dimethyl-3-phenyl-propan-1-ol, Benzylalkohol, 2-Phenylethan-1-ol, 3-Phenylpro- pan-1-ol, 4-Phenylbutan-1-ol, 5-Phenylpentan-1 -ol, 2-Benzylheptan-1-ol, 2,2-Dimethyl-3-phenyl- propan-1-ol, 2,2-Dimethyl-3-(3'-methylphenyl)-propan-1-ol, 2-Ethyl-3-phenylpropan-1-ol, 2-Ethyl-3- (3'-methylphenyl)-propan-1-ol, 3-(3'-Chlorphenyl)-2-ethylpropan-1-ol, 3-(2'-Chlorphenyl)-2- ethylpropan-1-ol, 3-(4'-Chlorphenyl)-2-ethylpropan-1-ol, 3-(3',4'-Dichlorphenyl)-2-ethylpropan-1-ol, 2-Ethyl-3-(2'-methylphenyl)-propan-1-ol, 2-Ethyl-3-(4'-methylphenyl)-propan-1-ol, 3-(3',4'-Dimethyl- phenyl)-2-ethylpropan-1-ol, 2-Ethyl-3-(4'-methoxyphenyl)-propan-1-ol, 3-(3',4'-Dimethoxyphenyl)-2- ethylpropan-1-ol, 2-Allyl-3-phenylpropan-1-ol und 2-n-Pentyl-3-phenylpropan-1-ol sowie Mischungen hiervon. Außerordentlich bevorzugt ist Phenoxyethanol, sowie Mischungen von 2-Benzylheptan-1-ol und Phenoxyethanol. Weitere besonders bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens einen Alkohol AA-1 , wie vorstehend beschrieben, in einer Gesamtmenge von 0,05 - 10 Gew.-%, bevorzugt 0, 1 - 5 Gew.-%, besonders bevorzugt 0,2 - 2 Gew.-%, außerordentlich bevorzugt 0,3 - 1 ,5 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Particularly preferred products according to the invention contain at least one alcohol AA-1, as described above, which is selected from phenoxyethanol, anisalcohol, 2-methyl-5-phenylpentan-1-ol, 1, 1-dimethyl-3-phenylpropane 1-ol, benzyl alcohol, 2-phenylethan-1-ol, 3-phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptan-1-ol, 2, 2-Dimethyl-3-phenyl-propan-1-ol, 2,2-dimethyl-3- (3'-methyl-phenyl) -propan-1-ol, 2-ethyl-3-phenylpropan-1-ol, 2-ethyl -3- (3'-methylphenyl) -propan-1-ol, 3- (3'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (2'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (4'-Chlorophenyl) -2-ethyl-propan-1-ol, 3- (3 ', 4'-dichlorophenyl) -2-ethyl-propan-1-ol, 2-ethyl-3- (2'-methyl-phenyl) - propan-1-ol, 2-ethyl-3- (4'-methylphenyl) -propan-1-ol, 3- (3 ', 4'-dimethylphenyl) -2-ethyl-propan-1-ol, 2-ethyl -3- (4'-methoxyphenyl) -propan-1-ol, 3- (3 ', 4'-dimethoxyphenyl) -2-ethyl-propan-1-ol, 2-allyl-3-phenyl-propan-1-ol and 2- n-Pentyl-3-phenylpropan-1-ol and mixtures thereof. Highly preferred is phenoxyethanol, as well as mixtures of 2-benzylheptan-1-ol and phenoxyethanol. Further particularly preferred compositions according to the invention comprise at least one alcohol AA-1, as described above, in a total amount of 0.05-10% by weight, preferably 0.1-1.5% by weight, more preferably 0.2-2% by weight .-%, most preferably 0.3 to 1, 5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
Erfindungsgemäß kann die kosmetische Zusammensetzung als weiteren Deodorant-Wirkstoff weiterhin mindestens eine Verbindung aus der Gruppe der Tropolone (I)
According to the invention, the cosmetic composition may furthermore comprise as further deodorant active ingredient at least one compound from the group of tropolones (I)
enthalten, wobei die Reste R1 bis R5 in Formel (I) unabhängig voneinander ausgewählt sind aus - H, -CH3, -CH2CH3, -(CH2)2CH3, -CH(CH3)2, -OH, -OR6 (mit R6 = -CH3, -CH2CH3, -(CH2)2CH3, - CH(CH3)2), -COOR7 (mit R7 = -CH3, -CH2CH3, -(CH2)2CH3, -CH(CH3)2), -N02, -NH2, -F, -Cl, -Br, -I. include, where the radicals R1 to R5 in formula (I) independently selected from - H, -CH3, -CH2CH3, - (CH 2) 2 CH 3, -CH (CH 3) 2, -OH, -OR 6 (with R6 = -CH3, -CH2CH3, - (CH 2) 2 CH 3, - CH (CH 3) 2), -COOR 7 (where R 7 = -CH 3, -CH 2 CH 3, - (CH 2) 2 CH 3 , -CH (CH 3 ) 2 ), -NO 2 , -NH 2 , -F, -Cl, -Br, -I.
Ganz besonders bevorzugte Tropolone sind das alpha-Tropolon sowie die drei isomeren Thujaplicine. Erfindungsgemäße bevorzugte Verwendungen sind dadurch gekennzeichnet, dass das bzw. die 1 ,2-Alkandiol(e) zusammen mit mindestens einer Verbindung aus der Gruppe Very particularly preferred tropolones are the alpha-tropolone and the three isomeric thujaplicins. Preferred uses according to the invention are characterized in that the or the 1,2-alkanediol (s) together with at least one compound from the group
- Tropolon (R1 = R2 = R3 = R4 = R5 = H in Formel (I)) - tropolone (R1 = R2 = R3 = R4 = R5 = H in formula (I))
- alpha-Thujaplicin (R1 = -(CH(CH3)2, R2 = R3 = R4 = R5 = H in Formel (I)) - alpha-thujaplicin (R1 = - (CH (CH 3) 2, R2 = R3 = R4 = R5 = H in the formula (I))
- beta-Thujaplicin (R2 = -(CH(CH3)2, R1 = R3 = R4 = R5 = H in Formel (I)) - beta-thujaplicin (R 2 = - (CH (CH 3 ) 2 , R 1 = R 3 = R 4 = R 5 = H in formula (I))
- gamma-Thujaplicin (R3 = -(CH(CH3)2, R1 = R2 = R4 = R5 = H in Formel (I)) verwendet werden. - gamma-thujaplicin (R3 = - (CH (CH 3) 2, R1 = R2 = R4 = R5 = H are used in formula (I)).
Besonders bevorzugt enthält die kosmetische Zusammensetzung Tropolon (2-Hydroxy-2,4,6- Cycloheptatrienon), bevorzugt in einer Menge von 0,001 - 0, 1 Gew.-%, bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. The cosmetic composition particularly preferably contains tropolone (2-hydroxy-2,4,6-cycloheptatrienone), preferably in an amount of 0.001-0.1% by weight, based on the weight of the composition, without taking into account any propellant present ,
Weitere bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an dem Deodorant-Wirkstoff Triethylcitrat. Triethylcitrat ist ein bekannter Deodorantwirkstoff, der als Enzyminhibitor für Esterasen und Lipasen wirkt und somit zur Breitbandwirkung erfindungsgemäßer Mittel beiträgt. Bevorzugte erfindungsgemäße Mittel enthalten 0,5 - 15 Gew.-%, bevorzugt 3 - 8 Gew.-%, außerordentlich bevorzugt 4 - 7 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Further preferred agents according to the invention are characterized by a content of the deodorant active ingredient triethyl citrate. Triethyl citrate is a known deodorant active which acts as an enzyme inhibitor for esterases and lipases and thus contributes to the broad spectrum effect of agents according to the invention. Preferred agents according to the invention contain from 0.5 to 15% by weight, preferably from 3 to 8% by weight, most preferably from 4 to 7% by weight, based in each case on the weight of the composition, without taking into account any blowing agent present.
Die kosmetische Zusammensetzung kann erfindungsgemäß weiterhin als antibakteriell wirkenden Deodorant-Wirkstoff Teebaumöl enthalten, der im Handel als Melalleuca Alternifolia Leaf Oil erhältlich ist, bspw. als Melafresh® T96 von Southern Cross Botanicals. Die Menge hiervon beträgt bevorzugt 0.01 bis 0,5 Gew.-%, bevorzugter 0,05 bis 0,2 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. According to the invention, the cosmetic composition may further contain, as an antibacterial deodorant active ingredient, tea tree oil which is commercially available as Melalleuca Alternifolia Leaf Oil, for example as Melafresh® T96 from Southern Cross Botanicals. The amount thereof is preferably 0.01 to 0.5 wt .-%, more preferably 0.05 to 0.2 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
Apokriner Schweiß stellt eine komplexe Mischung dar, die unter anderem Sebum und andere Fette sowie Steroide enthält. Steroide selbst sind nicht wasserlöslich. Um mit den Körperflüssigkeiten abtransportiert werden zu können, liegen sie normalerweise als Sulfat oder als Glucuronid vor. Auf der
Haut erfolgt die Spaltung dieser Steroidester in die flüchtigen freien Steroide durch hydrolytische Enzyme der Hautbakterien, insbesondere der coryneformen Bakterien. Prinzipiell sind dazu alle bakteriellen Exoesterasen in der Lage, besonders aber die Enzyme Arylsulfatase und beta- Glucuronidase. Verbindungen, die Arylsulfatase oder beta-Glucuronidase inhibieren, stellen daher erfindungsgemäß bevorzugte Deodorantwirkstoffe dar. Apocrine sweat is a complex mixture that includes sebum and other fats as well as steroids. Steroids themselves are not water soluble. In order to be carried away with the body fluids, they are usually present as sulfate or as glucuronide. On the Skin is the cleavage of these steroid esters in the volatile free steroids by hydrolytic enzymes of the skin bacteria, especially the coryneform bacteria. In principle all bacterial exoesterases are capable of this, but especially the enzymes arylsulfatase and beta-glucuronidase. Compounds which inhibit arylsulfatase or beta-glucuronidase therefore represent preferred deodorant active ingredients according to the invention.
Die Entwicklung der kurz- und mittelkettigen Fettsäuren, die wesentlich zum Körpergeruch beitragen, beginnt mit der Spaltung von Hautlipiden zu verzweigten langkettigen Fettsäuren. Die Spaltung der Hautlipide, die überwiegend als Glycerinester vorliegen, erfolgt im Wesentlichen durch Propionibacterium, Corynebacterium A und Staphylococcus-Spezies (A.G. James et al., Generation and Turnover of Volatile Fatty Acids by Axillary Bacteria, 22nd IFSCC Congress, Edinburgh, 2002, Poster 108). A.G. James et al. offenbaren weiterhin, dass aus den langkettigen verzweigten Fettsäuren durch die hydrolytischen Enzyme von einem bestimmten Corynebacterium, das A.G. James et al. als Corynebacterium A bezeichnen, sowohl kurzkettige C2 - Cs-Fettsäuren als auch mittelkettige C6 - Ci2-Fettsäuren gebildet werden, die hauptsächlich für den axillaren Körpergeruch verantwortlich sind. Prinzipiell sind alle bakteriellen Exoesterasen zu dieser Lipidspaltung fähig, besonders aber das Enzym Lipase. Verbindungen, die Lipase inhibieren, stellen daher ebenfalls erfindungsgemäß bevorzugte Deodorantwirkstoffe dar. The development of short- and medium-chain fatty acids, which contribute significantly to body odor, begins with the cleavage of skin lipids to branched long-chain fatty acids. Cleavage of the skin lipids, predominantly as glycerol esters, is essentially by Propionibacterium, Corynebacterium A and Staphylococcus species (AG James et al., Generation and Turnover of Volatile Fatty Acids by Axillary Bacteria, 22 nd IFSCC Congress, Edinburgh, 2002, Poster 108). AG James et al. further disclose that from the long-chain branched fatty acids by the hydrolytic enzymes of a particular Corynebacterium, the AG James et al. as Corynebacterium A, both short - chain C2 - Cs fatty acids and medium chain C6 - Ci2 fatty acids are formed, which are mainly responsible for the axillary body odor. In principle, all bacterial exoesterases are capable of this lipid cleavage, but especially the enzyme lipase. Compounds which inhibit lipase are therefore also preferred deodorant agents according to the invention.
Eine weitere Verbindungsklasse, die ebenfalls bei der bakteriellen Zersetzung der Schweißbestandteile entsteht und zum Körpergeruch beiträgt, sind gesättigte und ungesättigte Aldehyde, vor allem solche mit einer Kettenlänge von C6 - C12, insbesondere Hexanal, Heptanal, Octenal und Nonenal. Diese entstehen durch beta-Spaltung aus den Hydroperoxiden, die unter Einwirkung der 5-Lipoxige- nase auf ungesättigte Fettsäuren gebildet werden. Verbindungen, die das Enzym 5-Lipoxigenase inhibieren, stellen daher ebenfalls erfindungsgemäß bevorzugte Deodorantwirkstoffe dar. Another class of compounds which also results from the bacterial decomposition of the sweat constituents and which contributes to body odor are saturated and unsaturated aldehydes, especially those with a chain length of C6-C12, in particular hexanal, heptanal, octenal and nonenal. These are formed by beta-cleavage from the hydroperoxides, which are formed by the action of the 5-lipoxygenase on unsaturated fatty acids. Compounds which inhibit the enzyme 5-lipoxygenase are therefore also preferred deodorant agents according to the invention.
Weiterhin ist bekannt, dass stark übel riechende Komponenten des menschlichen Körpergeruchs und Mundgeruchs insbesondere durch enzymatische Reaktion freigesetzte flüchtige Schwefelverbindungen, so genannte„volatile sulfur Compounds" (VSC), darstellen. Schwefelhaltige Verbindungen kommen als wasserlösliche Aminosäurekonjugate mit dem Schweiß auf die menschliche Haut. Dort werden sie von Hautbakterien (vor allem von Staphylokokken und Corynebakterien) durch enzymatische Reaktion freigesetzt. Ein Enzym, das bei der Freisetzung von VSCs eine besondere Rolle spielt, ist die Cystathionin-beta-Lyase. Dieses Enzym spaltet VSCs von den Aminosäuren ab und ist somit eine wichtige Ursache bei der Entstehung von Körpergeruch. Verbindungen, die das Enzym Cystathionin-beta-Lyase inhibieren, stellen daher ebenfalls erfindungsgemäß bevorzugte Deodorantwirkstoffe dar. Furthermore, it is known that highly foul-smelling components of human body odor and halitosis are, in particular, volatile sulfur compounds released by enzymatic reaction (so-called "volatile sulfur compounds" (VSC).) Sulfur-containing compounds come as water-soluble amino acid conjugates with sweat on the human skin They are released by enzymatic reactions from skin bacteria (especially staphylococci and corynebacteria), an enzyme that plays a key role in the release of VSCs, cystathionine beta-lyase, which cleaves VSCs from the amino acids and thus is an important cause in the development of body odor compounds which inhibit the enzyme cystathionine beta-lyase, therefore, also according to the invention are preferred deodorant agents.
Weitere bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor des Enzyms Arylsulfatase ist. Erfindungsgemäß bevorzugte
Deodorantwirkstoffe, die als Arylsulfatase-Inhibitor wirken, sind solche, wie sie in US 5643559, US 5676937, WO2001/099376 A2, EP 1430879 A1 und DE 10216368 A1 offenbart sind. Weitere besonders bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor des Enzyms Arylsulfatase ist, in einer Gesamtmenge von 0,001 - 10 Gew.-%, bevorzugt 0,01 - 5 Gew.-%, besonders bevorzugt 0,1 - 2,5 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Further preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme arylsulfatase. According to the invention preferred Deodorant active ingredients which act as arylsulfatase inhibitors are those disclosed in US 5643559, US 5676937, WO2001 / 099376 A2, EP1430879 A1 and DE 10216368 A1. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme arylsulfatase, in a total amount of 0.001-10 wt.%, Preferably 0.01-5 wt.%, Particularly preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
Weitere bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor des Enzyms beta-Glucuronidase ist. Erfindungsgemäß bevorzugte Deodorantwirkstoffe, die als beta-Glucuronidase-lnhibitor wirken, sind solche, wie sie in WO2003/039505 A2 offenbart sind. Weitere besonders bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor des Enzyms beta-Glucuronidase ist, in einer Gesamtmenge von 0,001 - 10 Gew.-%, bevorzugt 0,01 - 5 Gew.- %, besonders bevorzugt 0, 1 - 2,5 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Further preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme beta-glucuronidase. Deodorant active ingredients which are active according to the invention and act as a beta-glucuronidase inhibitor are those disclosed in WO2003 / 039505 A2. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme beta-glucuronidase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, more preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
Weitere bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor des Enzyms Lipase ist. Erfindungsgemäß bevorzugte Deodorantwirkstoffe, die als Lipase-Inhibitor wirken, sind ausgewählt aus denen, die in EP 1428520 A2 offenbart sind, weiterhin ausgewählt aus den Aminomethylenmalonsäure-Derivaten gemäß DE 3018132 A1 , den Ethylenoxid-Propylenoxid-Copolymeren gemäß GB 2335596 A1 und den Salzen der Phytinsäure gemäß EP 650 720 A1. Weitere besonders bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor des Enzyms Lipase ist, in einer Gesamtmenge von 0,001 - 10 Gew.-%, bevorzugt 0,01 - 5 Gew.-%, besonders bevorzugt 0,1 - 2,5 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Further preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme lipase. According to preferred deodorant active ingredients which act as lipase inhibitor are selected from those disclosed in EP 1428520 A2, further selected from the aminomethylenemalonic acid derivatives according to DE 3018132 A1, the ethylene oxide-propylene oxide copolymers according to GB 2335596 A1 and the salts of Phytic acid according to EP 650 720 A1. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme lipase, in a total amount of 0.001-10 wt.%, Preferably 0.01-5 wt.%, Particularly preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
Weitere besonders bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor der 5-Lipoxigenase ist. Erfindungsgemäß bevorzugte Deodorantwirkstoffe, die als 5-Lipoxigenase-lnhibitor wirken, sind in EP 1428519 A2 offenbart. Weitere besonders bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor des Enzyms 5-Lipoxigenase ist, in einer Gesamtmenge von 0,001 - 10 Gew.-%, bevorzugt 0,01 - 5 Gew.-%, besonders bevorzugt 0,1 - 2,5 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of 5-lipoxygenase. Deodorant active ingredients which are preferred according to the invention and act as 5-lipoxygenase inhibitors are disclosed in EP 1428519 A2. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme 5-lipoxygenase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, more preferably 0.1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.
Weitere besonders bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an
mindestens einer Verbindung, die ein Inhibitor des Enzyms Cystathionin-beta-Lyase ist. Erfindungsgemäß bevorzugte Deodorantwirkstoffe, die als Inhibitor der Cystathionin-beta-Lyase wirken, sind ausgewählt aus denen, die in EP 495918 B1 , WO 2006/079934, DE 102010000746 A1 , WO2010/031657 A1 und WO2010/046291 A1 offenbart sind. Weitere besonders bevorzugte erfindungsgemäße Mittel sind gekennzeichnet durch einen Gehalt an mindestens einer Verbindung, die ein Inhibitor des Enzyms Cystathionin-beta-Lyase ist, in einer Gesamtmenge von 0,001 - 10 Gew.- %, bevorzugt 0,01 - 5 Gew.-%, besonders bevorzugt 0,1 - 2,5 Gew.-%, jeweils bezogen auf das Gewicht der Zusammensetzung, ohne ggf. vorhandenes Treibmittel zu berücksichtigen. Further particularly preferred agents according to the invention are characterized by a content of at least one compound that is an inhibitor of the enzyme cystathionine beta-lyase. Deodorant active ingredients which are preferred according to the invention and act as inhibitors of cystathionine beta-lyase are selected from those disclosed in EP 495918 B1, WO 2006/079934, DE 10201000046 A1, WO2010 / 031657 A1 and WO2010 / 046291 A1. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme cystathionine beta-lyase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, particularly preferably 0.1-2.5% by weight, based in each case on the weight of the composition, of any propellant which may be present.
Weitere erfindungsgemäß bevorzugte Deodorant-Wirkstoffe sind Geruchsabsorber, desodorierend wirkende Ionenaustauscher, keimhemmende Mittel, präbiotisch wirksame Komponenten sowie Enzyminhibitoren oder, besonders bevorzugt, Kombinationen der genannten Wirkstoffe. Further inventively preferred deodorant active ingredients are odor absorbers, deodorizing ion exchangers, antimicrobial agents, prebiotic components and enzyme inhibitors or, more preferably, combinations of said active ingredients.
Silicate dienen als Geruchsabsorber, die auch gleichzeitig die rheologischen Eigenschaften der erfindungsgemäßen Zusammensetzung vorteilhaft unterstützen. Zu den erfindungsgemäß besonders bevorzugten Silicaten zählen vor allem Schichtsilicate und unter diesen insbesondere Montmorillonit, Kaolinit, Mit, Beidellit, Nontronit, Saponit, Hectorit, Bentonit, Smectit und Talkum. Weitere bevorzugte Geruchsabsorber sind beispielsweise Zeolithe, Zinkricinoleat, Cyclodextrine, bestimmte Metalloxide, wie z. B. Aluminiumoxid, sowie Chlorophyll. Sie sind bevorzugt in einer Gesamtmenge von 0,1 - 10 Gew.-%, besonders bevorzugt 0,5 - 7 Gew.-% und außerordentlich bevorzugt 1 - 5 Gew.-%, jeweils bezogen auf die Gesamtzusammensetzung ohne Treibmittel, enthalten. Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention. Among the silicates particularly preferred according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum. Other preferred odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably in a total amount of 0.1 to 10 wt .-%, more preferably 0.5 to 7 wt .-% and most preferably 1-5 wt .-%, each based on the total composition without propellant, included.
Unter keimhemmenden oder antimikrobiellen Wirkstoffen werden erfindungsgemäß solche Wirkstoffe verstanden, die die Zahl der an der Geruchsbildung beteiligten Hautkeime reduzieren bzw. deren Wachstum hemmen. Zu diesen Keimen zählen unter anderem verschiedene Spezies aus der Gruppe der Staphylokokken, der Gruppe der Corynebakterien, Anaerokokken und Mikrokokken. According to the invention, germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth. These organisms include, among others, various species from the group of staphylococci, the group of Corynebacteria, anaerococci and micrococci.
Als keimhemmende oder antimikrobielle Wirkstoffe erfindungsgemäß bevorzugt sind insbesondere Organohalogenverbindungen sowie -halogenide und eine Reihe von Pflanzenextrakten und. Hierzu zählen u. a. Triclosan, Chlorhexidin und 3,4,4'-Trichlorcarbanilid, Bromchlorophen, Dichlorophen, Chlorothymol, Chloroxylenol, Hexachlorophen, Dichloro-m-xylenol. Weiterhin sind Phenol, Terpenalkohole wie z. B. Farnesol und Chlorophyllin-Kupfer-Komplexe bevorzugte Deodorant- Wirkstoffe. As germ-inhibiting or antimicrobial agents according to the invention are particularly preferred organohalogen compounds and halides and a number of plant extracts and. These include u. a. Triclosan, chlorhexidine and 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol. Furthermore, phenol, terpene alcohols such. As farnesol and chlorophyllin copper complexes preferred deodorant agents.
Bevorzugte erfindungsgemäße Deodorant-Mittel enthalten als weiteren Bestandteil mindestens einen Deodorant-Wirkstoff, der ausgewählt ist aus aromatischen Alkoholen der Struktur AA-1 mit den vorstehend genannten Substituenten, bevorzugt Phenoxyethanol, 1 ,2-Alkandiolen mit 5 bis 7 Kohlenstoffatomen, Tropolon, Triethylcitrat sowie Mischungen hiervon. Preferred deodorant compositions according to the invention contain as further constituent at least one deodorant active ingredient which is selected from aromatic alcohols of structure AA-1 with the abovementioned substituents, preferably phenoxyethanol, 1,2-alkanediols having 5 to 7 carbon atoms, tropolone, triethyl citrate and Mixtures thereof.
Antioxidative Stoffe können der oxidativen Zersetzung der Schweißkomponenten entgegenwirken und auf diese Weise die Geruchsentwicklung hemmen. Bevorzugte Antioxidantien sind Imidazol und
Imidazolderivate (z. B. Urocaninsäure), Peptide, wie z. B. D,L-Carnosin, D-Carnosin, L-Carnosin und deren Derivate (z. B. Anserin), Carotinoide, Carotine (z. B. α-Carotin, ß-Carotin, Lycopin) und deren Derivate, Liponsäure und deren Derivate (z. B. Dihydroliponsäure), Aurothioglucose, Propylthiouracil und weitere Thioverbindungen (z. B. Thioglycerin, Thiosorbitol, Thioglycolsäure, Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Methyl-, Ethyl-, Propyl-, Amyl- , Butyl-, Lauryl-, Palmitoyl-, Oleyl-, γ-Linoleyl-, Cholesteryl- und Glycerylester) sowie deren Salze, Dilaurylthiodipropionat, Distearylthiodipropionat, Thiodipropionsäure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside und Salze) sowie Sulfoximinverbindungen (z. B. Buthioninsulfoximine, Homocysteinsulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathioninsulf- oximin) in sehr geringen verträglichen Dosierungen (z. B. pmol/kg bis μΐηοΙ/kg), ferner Metallchelatoren (z. B. α-Hydroxyfettsäuren, EDTA, EGTA, Lactoferrin), Huminsäuren, Gallensäure, Gallenextrakte, Catechine, Bilirubin, Biliverdin und deren Derivate, ungesättigte Fettsäuren und deren Derivate (z. B. γ-Linolensäure, Linolsäure, Arachidonsäure, Ölsäure), Folsäure und deren Derivate, Hydrochinon und dessen Derivate (z. B. Arbutin), Ubichinon und Ubichinol sowie deren Derivate, Vitamin C und dessen Derivate (z. B. Ascorbylpalmitat, -stearat, -dipalmitat, -acetat, Mg- Ascorbylphosphate, Natrium- und Magnesiumascorbat, Dinatriumascorbylphosphat und -sulfat, Kaliumascorbyltocopherylphosphat, Chitosanascorbat), Isoascorbinsäure und deren Derivate, Tocopherole und deren Derivate (z. B. Tocopherylacetat, -linoleat, -oleat und -succinat, Tocophereth-5, Tocophereth-10, Tocophereth-12, Tocophereth-18, Tocophereth-50, Tocophersolan), Vitamin A und Derivate (z. B. Vitamin-A-Palmitat), das Coniferylbenzoat des Benzoeharzes, Rutin, Rutinsäure und deren Derivate, Dinatriumrutinyldisulfat, Zimtsäure und deren Derivate, Kojisäure, Chitosanglycolat und -salicylat, Butylhydroxytoluol, Butylhydroxyanisol, Nordi- hydroguajakharzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophenon, Harnsäure und deren Derivate, Mannose und deren Derivate, Selen und Selen-Derivate (z. B. Selenmethionin), Stilbene und Stilben-Derivate (z. B. Stilbenoxid, trans-Stilbenoxid). Erfindungsgemäß können geeignete Derivate (Salze, Ester, Zucker, Nukleotide, Nukleoside, Peptide und Lipide) sowie Mischungen dieser genannten Wirkstoffe oder wasserfreie Pflanzen extra kte, die diese Antioxidantien enthalten, eingesetzt werden. Antioxidant substances can counteract the oxidative decomposition of the welding components and in this way inhibit odor development. Preferred antioxidants are imidazole and Imidazole derivatives (eg, urocanic acid), peptides, such as. B. D, L-carnosine, D-carnosine, L-carnosine and their derivatives (eg., Anserin), carotenoids, carotenes (eg, α-carotene, ß-carotene, lycopene) and their derivatives, lipoic acid and their derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thio compounds (eg thioglycerol, thiosorbitol, thioglycolic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl , Propyl, amyl, butyl, lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids , Nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthionine sulfoximines, homocysteine sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very low tolerated dosages (eg pmol / kg to μΐηοΙ / kg), furthermore Metal chelators (eg, α-hydroxy fatty acids, EDTA, EGTA, lactofe rrin), humic acids, bile acids, bile extracts, catechins, bilirubin, biliverdin and their derivatives, unsaturated fatty acids and their derivatives (eg. Gamma-linolenic acid, linoleic acid, arachidonic acid, oleic acid), folic acid and its derivatives, hydroquinone and its derivatives (eg arbutin), ubiquinone and ubiquinol and their derivatives, vitamin C and its derivatives (eg ascorbyl palmitate, stearate, dipalmitate, acetate, magnesium ascorbyl phosphates, sodium and magnesium ascorbate, disodium ascorbyl phosphate and sulfate, potassium ascorbyl tocopheryl phosphate, chitosan ascorbate), isoascorbic acid and its derivatives, tocopherols and their derivatives (for example tocopheryl acetate, linoleate, oleate and succinate, tocophereth-5, tocophereth-10, tocophereth-12, tocophereth-18, tocophereth-50, tocopherolan), vitamin A and derivatives (e.g., vitamin A palmitate), the benzylic resin coniferyl benzoate, rutin, rutinic acid, and their derivatives, disodiumtrininyldisulphate, cinnamic acid and its derivatives, kojic acid, chitosan glycolate and salicylate, butylhydroxytoluene, butylhydroxyanisole, nordihydroguaiacetic acid, nordihydroguiaretic acid, trihydroxybutyrophenone, urine and their derivatives, mannose and their derivatives, selenium and selenium derivatives (eg. Selenium methionine), stilbenes and stilbene derivatives (eg, stilbene oxide, trans-stilbene oxide). According to the invention, suitable derivatives (salts, esters, sugars, nucleotides, nucleosides, peptides and lipids) and mixtures of these active substances mentioned or anhydrous extra-kte plants which contain these antioxidants can be used.
Als lipophile, öllösliche Antioxidantien aus dieser Gruppe sind Tocopherol und dessen Derivate, insbesondere Tocopherylacetat (Vtiamin E Acetate), und Carotinoide sowie Butylhydroxytoluol und Butylhydroxyanisol bevorzugt. Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, in particular tocopheryl acetate (vinylamine acetate), and carotenoids, as well as butylhydroxytoluene and butylhydroxyanisole.
Bevorzugte erfindungsgemäße Zusammensetzungen, die als Emulsion oder Suspension vorliegen, enthalten bevorzugt weiterhin mindestens ein unter Normalbedingungen flüssiges kosmetisches Öl, das kein Riechstoff und kein ätherisches Öl ist. Preferred compositions according to the invention which are in the form of an emulsion or suspension preferably also contain at least one liquid under normal conditions, which is not a fragrance and is not an essential oil.
Das kosmetische Öl ist unter Normalbedingungen flüssig. Unter ätherischen Ölen werden erfindungsgemäß Gemische aus flüchtigen Komponenten verstanden, die durch Wasserdampfdestillation aus pflanzlichen Rohstoffen hergestellt werden, wie z. B. Citrusöle.
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Mittel enthalten weiterhin mindestens einen Riechstoff. Die Definition eines Riechstoffs im Sinne der vorliegenden Anmeldung stimmt überein mit der fachmännisch üblichen Definition, wie sie dem RÖMPP Chemie Lexikon, Stand Dezember 2007, entnommen werden kann. Danach ist ein Riechstoff eine chemische Verbindung mit Geruch und/oder Geschmack, der die Rezeptoren der Haarzellen des olfaktorischen Systems erregt (adäquater Reiz). Die hierzu notwendigen physikalischen und chemischen Eigenschaften sind eine niedrige Molmasse von maximal 300 g/mol, ein hoher Dampfdruck, minimale Wasser- und hohe Lipidlöslichkeit sowie schwache Polarität und das Vorliegen mindestens einer osmophoren Gruppe im Molekül. Um flüchtige, niedermolekulare Substanzen, die üblicherweise und auch im Sinne der vorliegenden Anmeldung nicht als Riechstoff, sondern vornehmlich als Lösemittel angesehen und verwendet werden, wie beispielsweise Ethanol, Propa- nol, Isopropanol und Aceton, von erfindungsgemäßen Riechstoffen abzugrenzen, weisen erfindungsgemäße Riechstoffe eine Molmasse von 74 bis 300 g/mol auf, enthalten mindestens eine osmophore Gruppe im Molekül und weisen einen Geruch und/oder Geschmack auf, das heißt, sie erregen die Rezeptoren der Haarzellen des olfaktorischen Systems. The cosmetic oil is liquid under normal conditions. Essential oils according to the invention are understood to mean mixtures of volatile components which are prepared by steam distillation from vegetable raw materials, such as. B. citrus oils. Particularly preferred deodorant or antiperspirant compositions according to the invention also contain at least one perfume. The definition of a fragrance in the sense of the present application is in accordance with the expert definition as it can be found in the RÖMPP Chemie Lexikon, as of December 2007. Thereafter, a fragrance is a chemical compound with odor and / or taste that excites the hair cell receptors of the olfactory system (adequate stimulus). The necessary physical and chemical properties are a low molecular weight of at most 300 g / mol, a high vapor pressure, minimal water and high lipid solubility and weak polarity and the presence of at least one osmophoric group in the molecule. To delineate volatile, low molecular weight substances, which are usually and also for the purposes of the present application not as a fragrance, but primarily as a solvent and used, such as ethanol, propanol, isopropanol and acetone, of fragrances according to the invention, fragrances according to the invention have a molecular weight from 74 to 300 g / mol, contain at least one osmophoric group in the molecule and have an odor and / or taste, that is, they excite the hair cell receptors of the olfactory system.
Als Riechstoffe können Parfüme, Parfümöle oder Parfümölbestandteile eingesetzt werden. Parfümöle bzw. Duftstoffe können erfindungsgemäß einzelne Riechstoffverbindungen, z. B. die synthetischen Produkte vom Typ der Ester, Ether, Aldehyde, Ketone, Alkohole und Kohlenwasserstoffe sein. Riechstoffverbindungen vom Typ der Ester sind z.B. Benzylacetat, Phenoxyethylisobutyrat, p-tert.- Butylcyclohexylacetat, Linalylacetat, Dimethylbenzylcarbinylacetat (DMBCA), Phenylethylacetat, Benzylacetat, Ethylmethylphenylglycinat, Allylcyclohexylpropionat, Styrallylpropionat, Benzylsalicylat, Cyclohexylsalicylat, Floramat, Melusat und Jasmecyclat. Zu den Ethern zählen beispielsweise Benzylethylether und Ambroxan , zu den Aldehyden z.B. die linearen Alkanale mit 8 - 18 C-Atomen, Citral, Citronellal, Citronellyloxy-acetaldehyd, Cyclamenaldehyd, Lilial und Bourgeonal, zu den Ketonen z.B. die Jonone, alpha-lsomethylionon und Methylcedrylketon, zu den Alkoholen Anethol, Citronellol, Eugenol, Geraniol, Linalool, Phenylethylalkohol und Terpineol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene wie Limonen und Pinen. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. As perfumes, perfumes, perfume oils or perfume oil ingredients can be used. Perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are known e.g. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate (DMBCA), phenylethylacetate, benzylacetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate. The ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g. the linear alkanals of 8 - 18 C atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones e.g. the ionones, alpha-lsomethylionone and methylcedryl ketone, the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance.
Besonders bevorzugte erfindungsgemäße Deodorant- oder Antitranspirant-Mittel enthalten mindestens einen Riechstoff in einer Gesamtmenge von 0,00001 bis 10 Gew.-%, bevorzugt 0,5 - 7 Gew.- %, außerordentlich bevorzugt 1 - 6 Gew.-%, jeweils bezogen auf das Gesamtgewicht des Mittels, ohne ggf. vorhandenes Treibmittel zu berücksichtigen.
Tabellarische Übersicht Particularly preferred deodorant or antiperspirant compositions according to the invention contain at least one perfume in a total amount of 0.00001 to 10 wt .-%, preferably 0.5 to 7 wt .-%, most preferably 1-6 wt .-%, each based on the total weight of the agent, without taking into account any existing propellant. Table overview
Die Zusammensetzung einiger bevorzugter kosmetischer Mittel kann den folgenden Tabellen entnommen werden (Angaben in Gew.-% bezogen auf das Gesamtgewicht des kosmetischen Mittels sofern nicht anders angegeben, ohne ggf. verwendetes Treibmittel zu berücksichtigen). The composition of some preferred cosmetic agents can be found in the following tables (figures in% by weight based on the total weight of the cosmetic composition, if not stated otherwise, without taking into account any possibly used propellant).
0,2 bis 1 ,0 Gew.-% in der kosmetischen Zusammensetzung enthalten, weiterhin bevorzugt 0,3 bis 0,5 Gew.-%. 0.2 to 1, 0 wt .-% in the cosmetic composition, further preferably 0.3 to 0.5 wt .-%.
Formel 1 1 b Formel 12b Formel 13b Formel 14b Formel Formula 1 1 b Formula 12b Formula 13b Formula 14b Formula
15b 15b
Wasser 0,1 bis 5,0 0,5 bis 5,0 1 ,0 bis 4,5 1 ,5 bis 4,0 2,5 bis 4,0Water 0.1 to 5.0 0.5 to 5.0 1, 0 to 4.5 1, 5 to 4.0 2.5 to 4.0
1 ,2-Octandiol 0,05 bis 3,0 0,1 bis 2,0 0,15 bis 0,2 bis 0,7 0,2 bis 0,5 1, 2-octanediol 0.05 to 3.0 0.1 to 2.0 0.15 to 0.2 to 0.7 0.2 to 0.5
1 ,0 1, 0
Ethylhexylglycerin 0,05 bis 2,0 0, 1 bis 1 ,5 0,2 bis 1 ,0 0,3 bis 0,7 0,3 bis 0,5 Ethylhexylglycerol 0.05 to 2.0, 1 to 1.5, 0.2 to 1.0, 0.3 to 0.7 0.3 to 0.5
Triethylcitrat 0,5 bis 15,0 1 ,0 bis 10,0 2,0 bis 8,0 3,0 bis 8,0 4,0 bis 7,0Triethyl citrate 0.5 to 15.0 1, 0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
Mise add 100 add 100 add 100 add 100 add 100
Formel 11c Formel 12c Formel 13c Formel 14c Formel Mise add 100 add 100 add 100 add 100 add 100 Formula 11c Formula 12c Formula 13c Formula 14c Formula
15c 15c
Wasser 0,1 bis 5,0 0,5 bis 5,0 1,0 bis 4,5 1,5 bis 4,0 2,5 bis 4,0Water 0.1 to 5.0 0.5 to 5.0 1.0 to 4.5 1.5 to 4.0 2.5 to 4.0
1,2-Alkandiolester mit 8 0,05 bis 1,0 0,1 bis 1,0 0,1 bis 0,5 0,2 bis 0,4 0,2 bis 0,3 bis 30 C-Atomen 1,2-alkanediol ester with 8 0.05 to 1.0 0.1 to 1.0 0.1 to 0.5 0.2 to 0.4 0.2 to 0.3 to 30 carbon atoms
1,2-Alkandiolether mit 8 0,05 bis 2,0 0,1 bis 1,5 0,2 bis 1,0 0,3 bis 0,7 0,3 bis 0,5 bis 30 C-Atomen 1,2-Alkandiolether with 8 0.05 to 2.0 0.1 to 1.5 0.2 to 1.0 0.3 to 0.7 0.3 to 0.5 to 30 carbon atoms
Triethylcitrat 0,5 bis 15,0 1,0 bis 10,0 2,0 bis 8,0 3,0 bis 8,0 4,0 bis 7,0 Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
Mise add 100 add 100 add 100 add 100 add 100 Mise add 100 add 100 add 100 add 100 add 100
Formel 11h Formel 12h Formel 13h Formel 14h Formel Formula 11h Formula 12h Formula 13h Formula 14h Formula
15h 15h
Wasser 0,1 bis 5,0 0,5 bis 5,0 1,0 bis 4,5 1,5 bis 4,0 2,5 bis 4,0Water 0.1 to 5.0 0.5 to 5.0 1.0 to 4.5 1.5 to 4.0 2.5 to 4.0
1,2-Octandiol 0,05 bis 3,0 0,1 bis 2,0 0,15 bis 0,2 bis 0,7 0,2 bis 0,5 1,2-octanediol 0.05 to 3.0 0.1 to 2.0 0.15 to 0.2 to 0.7 0.2 to 0.5
1,0 1.0
Ethylhexylglycerin 0,05 bis 2,0 0,1 bis 1,5 0,2 bis 1,0 0,3 bis 0,7 0,3 bis 0,5 Ethylhexylglycerol 0.05 to 2.0 0.1 to 1.5 0.2 to 1.0 0.3 to 0.7 0.3 to 0.5
Triglycerincaprylat, 0,05 bis 1,0 0,1 bis 1,0 0,1 bis 0,5 0,2 bis 0,4 0,2 bis 0,3 Diglycerincaprylat Triglyceryl acrylate, 0.05 to 1.0 0.1 to 1.0 0.1 to 0.5 0.2 to 0.4 0.2 to 0.3 diglyceryl acrylate
und/oder Glycerincaprylat and / or glycerol acrylate
Triethylcitrat 0,5 bis 15,0 1,0 bis 10,0 2,0 bis 8,0 3,0 bis 8,0 4,0 bis 7,0 Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
Mise add 100 add 100 add 100 add 100 add 100 Mise add 100 add 100 add 100 add 100 add 100
Formel 21b Formel 22b Formel 23b Formel 24b Formel Formula 21b Formula 22b Formula 23b Formula 24b Formula
25b 25b
Wasser 0,1 bis 5,0 0,5 bis 5,0 1,0 bis 4,5 1,5 bis 4,0 2,5 bis 4,0Water 0.1 to 5.0 0.5 to 5.0 1.0 to 4.5 1.5 to 4.0 2.5 to 4.0
1,2-Octandiol 0,05 bis 3,0 0,1 bis 2,0 0,15 bis 0,2 bis 0,7 0,2 bis 0,5 1,2-octanediol 0.05 to 3.0 0.1 to 2.0 0.15 to 0.2 to 0.7 0.2 to 0.5
1,0 1.0
Ethylhexylglycerin 0,05 bis 2,0 0,1 bis 1,5 0,2 bis 1,0 0,3 bis 0,7 0,3 bis 0,5 Ethylhexylglycerol 0.05 to 2.0 0.1 to 1.5 0.2 to 1.0 0.3 to 0.7 0.3 to 0.5
Triethylcitrat 0,5 bis 15,0 1,0 bis 10,0 2,0 bis 8,0 3,0 bis 8,0 4,0 bis 7,0Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
Phenoxyethanol 0,05 bis 10,0 0,1 bis 5,0 0,2 bis 3,0 0,3 bis 2,0 0,5 bis 1,5Phenoxyethanol 0.05 to 10.0 0.1 to 5.0 0.2 to 3.0 0.3 to 2.0 0.5 to 1.5
Mise add 100 add 100 add 100 add 100 add 100
Formel 21c Formel 22c Formel 23c Formel 24c Formel Mise add 100 add 100 add 100 add 100 add 100 Formula 21c Formula 22c Formula 23c Formula 24c Formula
25c 25c
Wasser 0,1 bis 5,0 0,5 bis 5,0 1,0 bis 4,5 1,5 bis 4,0 2,5 bis 4,0Water 0.1 to 5.0 0.5 to 5.0 1.0 to 4.5 1.5 to 4.0 2.5 to 4.0
1,2-Alkandiolester mit 8 0,05 bis 1,0 0,1 bis 1,0 0,1 bis 0,5 0,2 bis 0,4 0,2 bis 0,3 bis 30 C-Atomen 1,2-alkanediol ester with 8 0.05 to 1.0 0.1 to 1.0 0.1 to 0.5 0.2 to 0.4 0.2 to 0.3 to 30 carbon atoms
1,2-Alkandiolether mit 8 0,05 bis 2,0 0,1 bis 1,5 0,2 bis 1,0 0,3 bis 0,7 0,3 bis 0,5 bis 30 C-Atomen 1,2-Alkandiolether with 8 0.05 to 2.0 0.1 to 1.5 0.2 to 1.0 0.3 to 0.7 0.3 to 0.5 to 30 carbon atoms
Triethylcitrat 0,5 bis 15,0 1,0 bis 10,0 2,0 bis 8,0 3,0 bis 8,0 4,0 bis 7,0 Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
Phenoxyethanol 0,05 bis 10,0 0,1 bis 5,0 0,2 bis 3,0 0,3 bis 2,0 0,5 bis 1,5Phenoxyethanol 0.05 to 10.0 0.1 to 5.0 0.2 to 3.0 0.3 to 2.0 0.5 to 1.5
Mise add 100 add 100 add 100 add 100 add 100 Mise add 100 add 100 add 100 add 100 add 100
Formel 21f Formel 22f Formel 23f Formel 24f Formel 25fFormula 21f Formula 22f Formula 23f Formula 24f Formula 25f
Wasser 0,1 bis 5,0 0,5 bis 5,0 1,0 bis 4,5 1,5 bis 4,0 2,5 bis 4,0Water 0.1 to 5.0 0.5 to 5.0 1.0 to 4.5 1.5 to 4.0 2.5 to 4.0
2-Methyl-5- 0,05 bis 1,0 0,1 bis 1,0 0,2 bis 0,8 0,3 bis 0,7 0,4 bis 0,6 Cyclohexylpentanol 2-methyl-5- 0.05 to 1.0 0.1 to 1.0 0.2 to 0.8 0.3 to 0.7 0.4 to 0.6 cyclohexylpentanol
Ethylhexylglycerin 0,05 bis 2,0 0,1 bis 1,5 0,2 bis 1,0 0,3 bis 0,7 0,3 bis 0,5 Ethylhexylglycerol 0.05 to 2.0 0.1 to 1.5 0.2 to 1.0 0.3 to 0.7 0.3 to 0.5
Triethylcitrat 0,5 bis 15,0 1,0 bis 10,0 2,0 bis 8,0 3,0 bis 8,0 4,0 bis 7,0Triethyl citrate 0.5 to 15.0 1.0 to 10.0 2.0 to 8.0 3.0 to 8.0 4.0 to 7.0
Phenoxyethanol 0,05 bis 10,0 0,1 bis 5,0 0,2 bis 3,0 0,3 bis 2,0 0,5 bis 1,5Phenoxyethanol 0.05 to 10.0 0.1 to 5.0 0.2 to 3.0 0.3 to 2.0 0.5 to 1.5
Unter "Mise" ist erfindungsgemäß Ethanol als kosmetischer Träger zu verstehen, und ggf. weitere übliche Bestandteile von Deodorants.
According to the invention, "Mise" is to be understood as meaning ethanol as a cosmetic carrier, and possibly further customary constituents of deodorants.
Ausführunqsbeispiele EXEMPLARY EMBODIMENTS
Die nachfolgenden Formulierungsbeispiele sollen den Gegenstand der Erfindung erläutern, ohne ihn hierauf zu beschränken. The following formulation examples are intended to illustrate the subject matter of the invention without limiting it thereto.
Die nachfolgend in der Tabelle beschriebenen kosmetischen Zusammensetzungen wurden hergestellt. Die Zusammensetzungen 1 bis 6 wurden dabei im Gewichtsverhältnis von 1 :3 mit dem Treibmittel Propan/Butan (15/85) in epoxy-beschichteten Aluminiumdosen (Lack: PPG7940) mit Ventilteller aus Weißblech abegefüllt. The cosmetic compositions described below in the table were prepared. The compositions 1 to 6 were in this case in a weight ratio of 1: 3 with the propellant propane / butane (15/85) in epoxy-coated aluminum cans (varnish: PPG7940) filled with valve plate made of tinplate.
Versprühbare Deodorants (Angaben in Gew.-%) Sprayable deodorants (in% by weight)
Ergebnisse: Results:
Alle Rezepturen 1 bis 6 wiesen eine elektrische Leitfähigkeit von < 50 μ8/ϋΐη auf. Die Leitfähigkeit nahm im Verlauf von mehreren Wochen nicht zu. Eine Korrosion der metallischen Oberfläche/Bauteile des Behälters wurde nicht beobachtet.
All formulations 1 to 6 had an electrical conductivity of <50 μ8 / ηη. Conductivity did not increase over several weeks. Corrosion of the metallic surface / components of the container was not observed.
Claims
1. Deodorierendes kosmetisches Mittel in einem Behälter, der bei Lagerung oder Dosierung des kosmetischen Mittels mindestens einen mit dem kosmetischen Mittel in Kontakt stehenden metallischen Oberflächenbereich und/oder mindestens ein mit dem kosmetischen Mittel in Kontakt stehendes metallisches Bauteil aufweist, wobei das kosmetische Mittel enthält: 1. Deodorant cosmetic agent in a container which has at least one metallic surface area in contact with the cosmetic agent during storage or dosage of the cosmetic agent and / or at least one metallic component in contact with the cosmetic agent, wherein the cosmetic agent contains:
- 0,1 bis 5,0 Gew.-% Wasser, 0.1 to 5.0% by weight of water,
- Ethanol - ethanol
- 0,1 bis 5,0 Gew.-% mindestens zweier verschiedener nichtionischer gesättigter aliphatischer Alkoholverbindungen mit 8 oder mehr Kohlenstoffatomen als Deodorant-Wirkstoffe, wobei sich die Gew.-%-Angaben jeweils auf das Gesamtgewicht des erfindungsgemäßen Mittels beziehen, ohne ggf. vorhandenes Treibmittel zu berücksichtigen, und 0.1 to 5.0% by weight of at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms as deodorant active ingredients, the weight percentages in each case referring to the total weight of the composition according to the invention, without to consider existing propellants, and
wobei das kosmetische Mittel eine elektrische Leitfähigkeit von 50 μβ/ϋΐη oder weniger aufweist. wherein the cosmetic agent has an electrical conductivity of 50 μβ / ϋΐη or less.
2. Kosmetisches Mittel nach Anspruch 1 , wobei der Behälter ein Metallaerosolsprühbehälter ist. 2. A cosmetic composition according to claim 1, wherein the container is a metal aerosol spray container.
3. Kosmetisches Mittel nach Anspruch 1 oder 2, wobei die aliphatischen Alkoholverbindungen aus der Gruppe ausgewählt sind, bestehend aus einer gesättigten aliphatischen Verbindung mit einer oder mehreren 1 ,2-Alkandiolgruppe(n) und einem einwertigen Alkohol. A cosmetic composition according to claim 1 or 2, wherein the aliphatic alcohol compounds are selected from the group consisting of a saturated aliphatic compound having one or more 1,2-alkanediol group (s) and a monohydric alcohol.
4. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei die Verbindung mit einer oder mehreren 1 ,2-Alkandiolgruppe(n) ein lineares oder verzweigtes 1 ,2-Alkandiol mit 8 bis 12 Kohlenstoffatomen, ein linearer oder verzweigter 1 ,2-Alkandiolether mit 8 bis 30 Kohlenstoffatomen und/oder ein linearer oder verzweigter 1 ,2-Alkandiolester mit 8 bis 30 Kohlenstoffatomen ist. 4. A cosmetic composition according to any one of the preceding claims, wherein the compound having one or more 1, 2-alkanediol group (s) a linear or branched 1, 2-alkanediol having 8 to 12 carbon atoms, a linear or branched 1, 2-alkane diol ethers 8 to 30 carbon atoms and / or a linear or branched 1, 2-alkanediol ester having 8 to 30 carbon atoms.
5. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei das 1 ,2-Alkandiol 1 ,2- Octandiol und/oder 1 ,2-Decandiol ist. 5. Cosmetic composition according to one of the preceding claims, wherein the 1, 2-alkane diol 1, 2-octanediol and / or 1, 2-decanediol.
6. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei der 1 ,2-Alkandiolether ein a-Monoalkylglycerinether mit einem verzweigten oder linearen gesättigten oder ungesättigten C8-C22-Alkylrest ist, bevorzugt α -(2-Ethylhexyl)glycerinether. 6. A cosmetic composition according to any one of the preceding claims, wherein the 1, 2-alkane diol is an a-monoalkyl glycerol ether having a branched or linear saturated or unsaturated C8-C22 alkyl radical, preferably α - (2-ethylhexyl) glycerol ether.
7. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei der 1 ,2-Alkandiolester ein Carbonsäureester des Mono-, Di- und/oder Triglycerins ist, bevorzugt Glycerinmonocaprylate, Glycerindicaprylate und/oder Glycerintricaprylate. 7. Cosmetic composition according to one of the preceding claims, wherein the 1, 2-alkanediol ester is a carboxylic acid ester of mono-, di- and / or triglycerol, preferably glycerol monocaprylates, glycerol dicaprylates and / or glycerol tricaprylates.
8. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei der einwertige Alkohol ein linearer oder verzweigter Alkohol mit 8 bis 30 Kohlenstoffatomen und einer endständigen OH-
Gruppe ist, der bevorzugt einen alicyclischen Ring aufweist. 8. Cosmetic composition according to one of the preceding claims, wherein the monohydric alcohol is a linear or branched alcohol having 8 to 30 carbon atoms and a terminal OH Group which preferably has an alicyclic ring.
9. Kosmetisches Mittel nach Anspruch 8, wobei der einwertige Alkohol 2-Methyl-5- Cyclohexylpentanol ist. A cosmetic composition according to claim 8, wherein the monohydric alcohol is 2-methyl-5-cyclohexylpentanol.
10. Kosmetisches Mittel nach einem der vorhergehenden Ansprüche, wobei das Mittel weiterhin eine oder mehrere der folgenden Verbindungen enthält: Phenoxyethanol, ein oder mehrere Tropolone, Triethylcitrat. 10. Cosmetic composition according to one of the preceding claims, wherein the agent further comprises one or more of the following compounds: phenoxyethanol, one or more tropolones, triethyl citrate.
1 1. Verwendung eines kosmetischen Mittels, welches 0, 1 bis 5,0 Gew.-% Wasser, Ethanol und 0,1 bis 5,0 Gew.-% mindestens zweier verschiedener nichtionischer gesättigter aliphatischer Alkoholverbindungen mit 8 oder mehr Kohlenstoffatomen als Deodorant-Wirkstoffe enthält, und welches eine elektrische Leitfähigkeit von 50 μβ/ϋΐη oder weniger aufweist, als Inhalt eines Behälters derart, dass bei Lagerung oder Dosierung des kosmetischen Mittels mindestens ein metallischer Oberflächenbereich und/oder mindestens ein metallisches Bauteil des Behälters mit dem kosmetischen Mittel in Kontakt steht.
1 1. Use of a cosmetic composition comprising 0, 1 to 5.0 wt .-% water, ethanol and 0.1 to 5.0 wt .-% of at least two different nonionic saturated aliphatic alcohol compounds having 8 or more carbon atoms as deodorant Containing active ingredients, and which has an electrical conductivity of 50 μβ / ϋΐη or less, as contents of a container such that upon storage or dosage of the cosmetic at least one metallic surface area and / or at least one metallic component of the container with the cosmetic in contact stands.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102014217316.7A DE102014217316A1 (en) | 2014-08-29 | 2014-08-29 | Low-electrolyte preparations against body odor |
DE102014217316.7 | 2014-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016030060A1 true WO2016030060A1 (en) | 2016-03-03 |
Family
ID=53514174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2015/065181 WO2016030060A1 (en) | 2014-08-29 | 2015-07-03 | Anti body odor preparations which are low in electrolytes |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102014217316A1 (en) |
WO (1) | WO2016030060A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4424298A3 (en) * | 2024-05-18 | 2025-04-09 | Clariant International Ltd | Antimicrobial compositions |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995026708A2 (en) * | 1994-04-05 | 1995-10-12 | Beiersdorf Ag | Novel deodorising and anti-microbial compositions for use in cosmetic or topical preparations |
DE19541967A1 (en) * | 1995-11-10 | 1997-05-15 | Beiersdorf Ag | Combination, useful as deodorant for personal care |
WO2009101216A2 (en) * | 2009-04-28 | 2009-08-20 | Symrise Gmbh & Co. Kg | Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3018132A1 (en) | 1980-05-12 | 1981-11-19 | Henkel Kgaa | Anti-acne and deodorant skin-care preparations - contg. amino:methylene-malonic acid derivs. which inhibit esterase and lipase enzymes secretions from skin bacteria |
DK0495918T3 (en) | 1989-10-10 | 1996-02-19 | Gillette Co | Amino acid beta-lyase enzyme inhibitors as deodorants |
US5643559A (en) | 1991-10-30 | 1997-07-01 | Colgate-Palmolive Company | Deodorant compositions comprising inhibitors of odor-producing axillary bacterial exoenzymes |
EP0650720A1 (en) | 1993-10-28 | 1995-05-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | Skin care and deodorant compositions |
GB2335596A (en) | 1998-03-24 | 1999-09-29 | Procter & Gamble | Polyalkyleneglycol Copolymers as Lipase Inhibitors |
RU2003138141A (en) | 2001-06-01 | 2005-06-10 | Хенкель Кгаа (De) | Arylsulfatase Inhibitors in Deodorants and Antiperspirants |
DE10154368A1 (en) | 2001-11-06 | 2003-05-15 | Henkel Kgaa | Beta-glucuronidase inhibitors in deodorants and antiperspirants |
DE10216368A1 (en) | 2002-04-12 | 2003-10-16 | Henkel Kgaa | Reducing body odor, e.g. in men, comprises applying deodorant or antiperspirant composition containing arylsulfatase-inhibiting phenoxyphenol derivative to skin |
DE10257738A1 (en) | 2002-12-10 | 2004-06-24 | Henkel Kgaa | 5-lipoxigenase inhibitors in deodorants and antiperspirants |
DE10260954A1 (en) | 2002-12-20 | 2004-07-01 | Henkel Kgaa | Arylsulfatase inhibitors in deodorants and antiperspirants |
BRPI0607207B1 (en) | 2005-01-31 | 2021-10-13 | Firmenich S.A | METHOD FOR SCREENING COMPOUNDS AND COMPOUND TO AVOID MAL ODOUR IN SWEAT HAVING THE ABILITY TO REDUCE THE DEVELOPMENT OF MAL ODOUR AND TO METABOLIZE A COMPOUND UNDER CONTROLLED CONDITIONS |
DE102008047743A1 (en) | 2008-09-17 | 2010-04-15 | Henkel Ag & Co. Kgaa | Use of urea derivatives and phenacylthiazolium salts for the treatment of body odor |
DE102008053034A1 (en) | 2008-10-24 | 2010-04-29 | Henkel Ag & Co. Kgaa | Use of hydroxycinnamic acids and their derivatives and / or plant extracts for the treatment of body odor |
DE102010000746A1 (en) | 2010-01-08 | 2011-01-27 | Henkel Ag & Co. Kgaa | Use of 1,2-alkanediol compounds for the prevention or treatment of body odor, preferably in the axillary or oral area, and in a cosmetic or pharmaceutical agent, which is useful as a deodorant, antiperspirant or a composition for oral care |
-
2014
- 2014-08-29 DE DE102014217316.7A patent/DE102014217316A1/en not_active Withdrawn
-
2015
- 2015-07-03 WO PCT/EP2015/065181 patent/WO2016030060A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995026708A2 (en) * | 1994-04-05 | 1995-10-12 | Beiersdorf Ag | Novel deodorising and anti-microbial compositions for use in cosmetic or topical preparations |
DE19541967A1 (en) * | 1995-11-10 | 1997-05-15 | Beiersdorf Ag | Combination, useful as deodorant for personal care |
WO2009101216A2 (en) * | 2009-04-28 | 2009-08-20 | Symrise Gmbh & Co. Kg | Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor |
Non-Patent Citations (1)
Title |
---|
D M HOWARD: "Principles of corrosion of metal containers by cosmetic products", J. SOC. COSMETIC CHEMISTS, 1 January 1969 (1969-01-01), pages 17 - 29, XP055207812, Retrieved from the Internet <URL:http://journal.scconline.org/pdf/cc1969/cc020n01/p00017-p00029.pdf> [retrieved on 20150814] * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4424298A3 (en) * | 2024-05-18 | 2025-04-09 | Clariant International Ltd | Antimicrobial compositions |
Also Published As
Publication number | Publication date |
---|---|
DE102014217316A1 (en) | 2016-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0636359B1 (en) | Deodorant mixture based on alpha-omega alkanoic dicarboxylic acids and wool wax acids | |
DE69829964T2 (en) | WATER FREE MONEYODORANT COMPOSITIONS | |
ES2636894T3 (en) | Sunscreen composition comprising hydroxyapatite as a physical sunscreen | |
DE102008011692A1 (en) | Active substance combination and their use | |
DE102017201025A1 (en) | "Cosmetic compositions containing a combination of at least two different active substances" | |
EP2175829B1 (en) | Use of short-chain vicinal diols as agents having antiperspirant activity | |
DE19631004A1 (en) | Deodorizing combinations of active substances based on woollysilicic acids, partial glycerides and aryl compounds | |
EP3154509B1 (en) | Cosmetic compositions for bleaching the skin | |
DE4438588A1 (en) | Against blemished skin, mild forms of acne and Propionibacterium acnes active ingredient combinations based on wool wax acids and glycerol esters of saturated fatty acids | |
DE102018220966A1 (en) | DEODORANT COMPOSITIONS INCLUDING CALCIUM SILICATE AND SODIUM BICARBONATE | |
WO2016066801A1 (en) | Cosmetic antiperspirant composition | |
JP2017081895A (en) | Oil-in-water emulsion composition | |
DE102018220964A1 (en) | WATER-FREE COSMETIC DEODORANT COMPOSITION COMPRISING CALCIUM CARBONATE | |
WO2015144326A1 (en) | Active-ingredient combinations consisting of 4-hydroxyacetophenone and one or more glycerin and/or oligoglycerin esters of branched chains and/or unbranched chains of alkane carboxylic acids, and cosmetic or dermatological preparations containing said active-ingredient combinations | |
DE102010034389B4 (en) | Stabilized W / O emulsions | |
WO2013092114A2 (en) | Deodorants and antiperspirants having stabilized antioxidant | |
WO2016030060A1 (en) | Anti body odor preparations which are low in electrolytes | |
DE102009004269A1 (en) | Diols as an antiperspirant active agent | |
DE102016221154A1 (en) | Cosmetic compositions containing a combination of at least two different active ingredients | |
DE102016221155A1 (en) | Cosmetic compositions containing a combination of at least two different active ingredients | |
DE3015450A1 (en) | ANTI-TRANSPIRANT | |
DE4436270C1 (en) | Use of chlorogenic acid as an antioxidant in hair cosmetic preparations | |
DE19519404A1 (en) | Body deodorant | |
JP7041500B2 (en) | Skin cosmetics | |
DE102009050854A1 (en) | Use of menthyl ethers as antibacterial, antimycotic or antiviral agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15734347 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15734347 Country of ref document: EP Kind code of ref document: A1 |